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In the past few decades, considerable progress has been made in 
understanding the biophysical properties of proteins using small modular 
domains such as SH3 domains. However, there is a surprising lack of 
knowledge regarding how these properties are affected when the domain 
is placed back within its full-length multi-domain protein. Using a 
combination of expressed protein ligation (EPL) and in vivo amino acid 
replacement of tryptophans with tryptophan (Trp) analogues, we have 
developed an integrated approach that allows the domain-specific 
incorporation of optical probes into large recombinant proteins. The Src 
homology 3 (SH3) domain from the c-Crk-l adaptor protein has been 
labeled with a Trp analogue, 7-azatryptophan (7AW), using E.coli Trp 
auxotrophs. Biophysical analysis shows that incorporation of 7AW does 
not significantly perturb the structure or function of the isolated domain. 
Ligation of 7AW labeled SH3 domain to the c-Crk-l Src homology 2 (SH2) 
domain, via EPL, generated the multi-domain protein, c-Crk-l, with a 
domain specific label. Studies on this labeled protein show that the 
biochemical and thermodynamic properties of the SH3 domain do not 
change within the context of a larger multi-domain protein. We have also 
utilized this technique and segmental isotopic labeling to study the C-
terminal S H 3 (cSH3) domain of the signaling adaptor protein, Crk-ll. 
Several studies suggest that the cSH3 domain plays an important 
regulatory role in the protein. However, no structural information is 
available on this domain and relatively little is known about its binding 
partners. We have solved the solution NMR structure of the C-terminal 
SH3 domain and it adopts the standard SH3 fold comprising a five-
stranded p-barrel. Thermodynamic and kinetic studies show that the 
domain folds in a reversible two-state manner and that the stability of the 
fold is similar to that observed for other SH3 domains. Studies on the 
cSH3 domain specifically labeled within Crk-ll have provided the strongest 
evidence yet that the cSH3 domain interacts in an intramolecular fashion 
to regulate Crk-ll. The techniques developed here should be applicable to 
many other multi-domain proteins. This sets the stage for a better 
understanding of the biophysical properties of domains within these 
complex systems. 
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Chapter 1- Introduction 
Cell survival within an environment is governed by the ability to respond 
to various extracellular signals. Essentially, all cellular functions are 
modulated via networks of signaling proteins that transmit signals from the 
plasma membrane to the cytoplasm and the nucleus (Dueber et al., 2004; 
Pawson and Nash, 2003). The primary mechanism underlying signal 
transduction is the formation of transient protein-protein interactions. These 
protein-protein interactions can result in certain posttranslational 
modifications, targeting of the protein to specific subcellular location, release 
of chemical second messengers and modulation of protein activity. Over the 
last few decades, a large number of cellular proteins have been identified in 
eukaryotic cells that are involved in the process of signal transduction. 
However, if each of these proteins had a unique biological role, then there 
are simple not enough proteins to account for the sophisticated behavior of 
diverse cell types. This suggests that the signaling proteins must act in a 
combinatorial fashion to achieve such an exquisite variety of responses. 
Nature achieves this combinatorial expansion by utilizing a small number of 
modular protein domains that are joined together in various configurations to 
form larger signaling proteins (Schultz et al., 1998). Each domain has a 
characteristic functional property and consequently, the larger multi-domain 
protein has the potential to receive various signaling inputs and transmit 
several outputs (Lim, 2002). Signal transduction networks can then be built 
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up from various interacting pathways (Dueber et al., 2004; Pawson and 
Nash, 2003). 
Modular Signaling Domains 
There have been several (~80) modular signaling domains identified in 
eukaryotes (Schultz et al., 1998) that play an important role in signal 
transduction via protein-protein or protein-small molecule interactions 
(Pawson and Nash, 2003) (Table 1.1). Signaling proteins often contain 
many such modular domains covalently linked in various combinations to 
form larger multi-domain proteins. The linking of modular domains in this 
fashion can serve several purposes. A larger interaction surface and 
consequently, greater binding affinity, can be achieved if two domains 
recognize different sites in the same target (Pawson and Nash, 2000). On 
the other hand, the domains can interact with different targets thereby 
modulating the formation of large signaling complexes with several proteins 
(Dueber et al., 2004). This has been observed for signaling adaptor proteins 
such as Grb2, Nek and Crk, which recruit effector molecules to tyrosine 
kinases (Pawson and Scott, 1997). Modular domains can also interact in an 
intramolecular fashion to regulate the structure and function of a multi-
domain protein, such as the Src tyrosine kinase (Lim, 2002). 
Among the first modular signaling protein domains to be identified were 
the Src Homology 2 (SH2) and Src Homology 3 (SH3) domains (Kuriyan 
and Cowburn, 1997). The SH2 domain is comprised of ~100 residues and 
binds phosphotyrosine residues in the context of specific sequences 
(Table1.1). The SH2 domain-peptide interaction has been well 
characterized and this interaction has moderate affinity (K^ 0.1-1.0 nM) 
(Kuriyan and Cowburn, 1997). SH3 domains, on the other hand, are small 
(~60 residues) protein-protein interaction domains that recognize proline-
rich peptide motifs. They have been found within ~1000 proteins in various 





























Ca+2 ion and Acidic Phospholipids 
aX= any amino acid, p= phosphorylated amino acid, §= hydrophobic amino 
acid. 
organisms ranging from yeast to humans (Bateman et al., 2004). The 
sequence identity between different SH3 domains is low, ranging from 
1 5 % to 45%, with the average pairwise identity being around 2 7 % (Larson 
and Davidson, 2000) (Figure 1.1). Despite this, all SH3 domains fold in a 
similar manner to adopt a five-stranded p-barrel structure (currently 380 
structures in PDB) (Figure 1.2). This incongruity (i.e. low sequence 
homology vs. high structural homology) has made S H 3 domains an 
important model system for protein stability, dynamics and folding studies. 
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Figure 1.1. Primary sequence and secondary structure alignment of 
SH3 domains. Shaded in red are conserved residues involved in ligand 
binding and in blue are conserved residues of the hydrophobic core. 
Indeed, the folding properties of several SH3 domains has been well 
characterized (Filimonov et al., 1999; Grantcharova and Baker, 1997; 
Guijarro et al., 1998; Lim, 1994; Plaxco et al., 1998; Riddle et al., 1999; 
Riddle et al., 1997; Viguera et al., 1994; Zhang et al., 1994). SH3 domains 
fold in a rapid two-state manner with no detectable intermediates 
(Grantcharova and Baker, 1997; Plaxco et al., 1998; Viguera et al., 1994). 
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The folding transition state of SH3 domains consists of a relatively small 
number of conformers in which the distal loop and the type-ll (3-turn are 
ordered and interact with each other (Grantcharova et al., 2000) (Figure 
1.2). The transition state conformers also have a relatively well-formed 
hydrophobic core (Northey et al., 2002). Folding studies on SH3 domains 
have greatly extended our understanding of the forces governing the 
folding of a polypeptide chain into a three dimensional structure. 
Distal Loop > 
< RT-Loop 
nSrc Loop 
Figure 1.2. Structure of an S H 3 domain. The structure of the middle 
SH3 domain from a signaling adaptor protein, Crk-ll is shown (Wu et al., 
1995) (1CKA). All SH3 domains adopt a similar five-stranded p-barrel fold. 
Although considerable progress has been made in understanding the 
structural, functional and folding properties of proteins using small modular 
domains such as SH3 domains, there is a surprising lack of knowledge 
regarding how these properties are affected when the domain is placed 
back within its full-length protein. Since modular domains are always 
found in the context of multi-domain proteins, understanding structural and 
functional interplay between individual domains in this context is 
important. The lack of detailed biophysical analyses of domains within the 
context of multi-domain proteins reflects the paucity of tools that allow one 
to extract detailed biophysical information on a specific domain within the 
context of a large multi-domain protein. 
Incorporation of Optical Probes Into Proteins 
Traditionally, fluorescence spectroscopy has been utilized to great 
effect to study various aspects of protein biophysics such as protein 
folding, protein-protein interactions and protein dynamics (Lakowicz, 
1999). Tryptophan (Trp) is the dominant intrinsic fluorophore in proteins 
and has been particularly useful as a probe because it is sensitive to its 
local environment and is thus useful in reporting local changes in protein 
conformation (Lakowicz, 1999). In proteins containing several Trp 
residues, as is often the case in multi-domain proteins, it is difficult to 
isolate the spectral contributions of individual fluorophores. Site-directed 
mutagenesis is one possible solution to this problem, removing all but one 
of the Trp residues (Waldman, 1987). However, Trp residues are often 
part of the hydrophobic core of the protein and so mutating them runs the 
risk of destabilizing the protein and/or affecting its function. Extrinsic 
fluorescent probes like dansyl or related amino acid derivatives can also 
be incorporated into proteins, via modification of reactive residues like 
lysine and cysteine or via chemical synthesis (Cohen et al., 2002; 
Mannuzzu, 1996). This again carries the risk of destabilizing the protein 
and/or affecting its function. Moreover, external probes are usually not well 
suited to study processes such as protein folding, owing to their bulky 
nature. 
Ideally one would want to replace Trp residues in proteins with 
molecules that cause minimal perturbation in protein structure and have a 
unique spectroscopic signature, as is the case with Trp analogues. The 
use of Escherichia coli Trp auxotrophs to incorporate Trp analogues into 
proteins in place of Trp residues is thus an attractive alternative to site-
directed mutagenesis (Schlesinger, 1968). This approach has the inherent 
advantage that Trp analogues are structurally similar to tryptophan and in 
many instances have minimal effect on protein structure and function 
(Ross et al., 1997; Ross et al., 2000; Twine and Szabo, 2003). Indeed, 
different Trp analogues, such as 4-fluorotryptophan, 5-fluorotryptophan, 6-
fluorotryptophan, 7-azatryptophan (7AW) and 5-hydroxytryptophan (5-
O H W ) have been incorporated into several proteins (Ross et al., 2000) 
(Figure 1.3). The fluorotryptophan analogues are primarily utilized to 
incorporate 19F into proteins for N M R studies (Danielson and Falke, 1996). 
The spectral properties of 5-OHW and 7 A W are different from Trp, 











Figure 1.3. Tryptophan and its analogues. The most commonly used 
tryptophan analogues that have been incorporated into proteins using 
E.coliXrp auxotrophs. 
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Out of the several Trp analogues, 7 A W is ideally suited as a 
spectroscopic probe. The absorption spectrum of 7AW is red-shifted by 
10-15 nm relative to the absorption spectra of Trp and the emission 
spectrum is red-shifted by up to 50 nm. Thus the 7AW labeled protein can 
be selectively excited and observed in the presence of Trp residues (Ross 
et al., 1997). 7AW is highly sensitive to its environment (Ross et al., 1997; 
Ross et al., 2000), and can be used as a probe to study protein folding 
(Wong and Eftink, 1998a; Wong and Eftink, 1998b). The use of E.coli Trp 
auxotrophs to label proteins results in the global replacement of all Trp 
residues in the protein with Trp analogues. This would be a disadvantage 
in proteins where one wants to study a specific Trp residue among many, 
like in the case of multi-domain proteins. One solution to the problem is to 
utilize nonsense suppression mutagenesis approaches (Steward, 1997). 
In principle, these limitations can also be overcome using expressed 
protein ligation (EPL) (Muir, 2003; Muir et al., 1998). 
Expressed Protein Ligation 
EPL is a protein semi-synthesis approach that allows synthetic and/or 
recombinant polypeptides to be chemoselectively and regioselectively 
joined together via a peptide bond (Muir, 2003). The approach takes 
advantage of two processes; native chemical ligation (Dawson et al., 
1994) and protein splicing (Noren et al., 2000). 
Over the last ~15 years, chemical ligation has emerged as a powerful 
technique in chemical biology, allowing unprotected molecules to be 
selectively linked together in an aqueous environment. Chemical ligation 
was initially introduced to solve the decades old problem of how to 
chemically synthesize proteins from smaller, synthetically accessible, 
peptide building blocks (Gaertner et al., 1992; Schnolzer and Kent, 1992). 
However, the basic strategy has found widespread use in other areas, 
including carbohydrate synthesis (Hang and Bertozzi, 2001) and nucleic 
acid synthesis (Burbulis et al., 2005; Dose and Seitz, 2005; Ficht et al., 
2004; Lovrinovic et al., 2003). All chemical ligation strategies rely on the 
incorporation of "molecular velcro" at the appropriate locations within the 
reactive partners; that is, mutually reactive groups that are unreactive 
towards everything else in the molecules under the conditions used. 
Several chemoselective reactions are in common use in chemical biology, 
including oxime formation (Gaertner et al., 1992; Rose, 1994), the 
Staudinger ligation (Nilsson et al., 2000; Saxon et al., 2000; Saxon and 
Bertozzi, 2000) and Huisgen cycioaddition chemistry (Kolb and Sharpless, 
2003). 
By far the most commonly used peptide ligation approach is native 
chemical ligation (NCL) (Dawson et al., 1994) (Figure 1.4). In this reaction, 
two fully unprotected synthetic peptide fragments are reacted under 
neutral aqueous conditions with the formation of a normal (native) peptide 
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bond at the ligation site. The first step in NCL involves the chemoselective 
reaction between a peptide fragment containing an N-terminal cysteine 
residue (a-Cys) and a second peptide fragment containing a a-thioester 
group. The initial transthioesterification reaction is followed by a 
spontaneous intramolecular S^N acyl shift to generate an amide bond at 
the ligation junction. NCL is compatible with all naturally occurring 
functional groups found in proteins, including the sulfhydryl group of 
cysteine. Indeed, it is worth emphasizing that internal cysteine residues 
are permitted in both peptide segments due to the reversible nature of the 
initial transthioesterification step. NCL is a remarkably robust reaction that 
can be performed in the presence of chemical denaturants (Dawson et al., 
1994; Hackeng et al., 1999; Hackeng et al., 1997), detergents (Bianchi et 
al., 1999), lipids (Clayton et al., 2004; Hunter and Kochendoerfer, 2004), 
reducing agents (Dawson et al., 1994; Hackeng et al., 1999; Hackeng et 
al., 1997), organic solvents (Kochendoerfer et al., 1999) and even crude 
cell extracts (Yeo et al., 2003). The approach has undergone a number of 
important refinements since it was introduced. These include; the 
development of auxiliary groups that in favorable cases overcome the 
requirement for an a-Cys (Canne et al., 1996; Offer et al., 2002), the 
identification of catalytic thiol cofactors (Dawson et al., 1997), and the 
development of solution-phase and solid-phase sequential ligation 
strategies that allow several peptides to be linked together in series (Bang 
11 
and Kent, 2004; Camarero et al., 1998; Cotton et al., 1999). In addition, 
new S P P S approaches for the preparation of peptide a-thioesters (Alsina 
et al., 1999; Botti et al., 2004; Camarero et al., 2004; Ingenito et al., 1999; 
Ohta et al., 2006; Shin et al., 1999; Swinnen and Hilvert, 2000), promise to 
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Figure 1.4. Principle of Native Chemical Ligation (NCL). The two 
reacting peptides, one with a-Cys and one with a-thioester, are 
unprotected. The reaction occurs under aqueous conditions around 
neutral pH. 
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Protein splicing is a post-translational process in which a precursor 
protein undergoes a series of self-catalyzed intramolecular 
rearrangements that result in the removal of an internal protein domain, 
termed an intein, and the ligation of the two flanking polypeptides, referred 
to as the N- and C-exteins (Figure 1.5). Inteins are autocatalytic and 
remarkably promiscuous for the sequences of the two flanking sequences 
(Paulus, 2000). Biochemical studies have revealed the mechanism of 
protein splicing and have identified the key conserved residues within the 
intein family required for these steps (Chong et al., 1997; Chong et al., 
1998b; Xu and Perler, 1996). Most protein splicing reactions occur in cis 
and involves intact inteins; there are several split inteins that participate in 
a protein frans-splicing reaction. In this process, complementation of the 
intein fragments precedes the normal splicing reaction (Mills et al., 1998; 
Southworth et al., 1998; Wu et al., 1998; Yamazaki et al., 1998). 
Protein splicing has been exploited extensively in the areas of 
biotechnology and chemical biology. Many mutant c/'s-splicing inteins have 
been generated that can catalyse only the first (Chong et al., 1997; Chong 
et al., 1998a; Evans et al., 1999; Mathys et al., 1999; Southworth et al., 
1999; Xu and Perler, 1996) or last (Chong et al., 1998b; Mathys et al., 
1999; Southworth et al., 1999; Wood et al., 1999) steps of protein splicing. 
In each case, a protein of interest is expressed as an in-frame N- or C-
terminal fusion to the mutant intein, which is usually linked to an affinity 
13 
tag (Chong et al., 1997). Following purification, the protein of interest can 
be cleaved off the intein by addition of thiols (C-terminal cleavage, i.e. the 
protein corresponds to the N-extein) or by changing the pH and 
temperature of the solution (N-terminal cleavage, i.e. the protein 
corresponds to the C-extein). These intein-based expression systems can 
be used for the "traceless" purification of recombinant proteins (Chong et 
al., 1997). Importantly, intein-fusions provide a convenient route to 
recombinant proteins with an N-terminal cysteine or a C-terminal thioester. 
In EPL, an N-terminal cysteine (Cys) containing protein or peptide is 
specifically ligated to the C-terminus of a recombinant a-thioester protein, 
generated using an intein fusion (Figure 1.6). Importantly, EPL has no 
inherent size limitation, in terms of the target protein, and the final yields 
are comparable to recombinant protein expression (Muir, 2003). Indeed, 
EPL has been used to selectively label specific domains within large multi-
domain proteins with stable isotope probes for NMR (Camarero et al., 
2002; Ottesen et al., 2003; Xu et al., 1999). In this strategy, a uniformly 
labeled recombinant protein fragment is ligated to an unlabeled protein 
fragment. The end result is a 'block' labeled protein sample that gives rise 
to heteronuclear NMR spectra containing a subset of the resonances that 
one would have observed from the corresponding uniformly labeled 










1. Succinimide Formation 






Figure 1.5. Mechanism of Protein Splicing. The central intein 
protein domain catalyses a series of intramolecular acyl transfers. These 
intramolecular rearrangements result in the joining of the two flanking 
proteins (termed, N-extein and C-extein) via a peptide bond. 
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Figure 1.6. Principle of Expressed Protein Ligation (EPL). EPL is a 
semi-synthetic version of native chemical ligation in which two synthetic 
and/or recombinant polypeptides are chemically ligated together. Proteins 
expressed as intein fusions can be cleaved from the intein with a variety of 
thiols to give the a-thioester derivative. Proteins containing an N-terminal 
Cys can be made recombinantly by masking the Cys with a protease tag. 
The two building blocks can also be synthesized by SPPS. 
In a similar vein, it should be possible to incorporate optical probes, 
like 7 A W , into large proteins in a domain specific manner to reduce 
spectroscopic complexity in a sample with multiple fluorophores (Figure 
1.7). In this study we have developed and applied this strategy to study 
16 
the effect of context on the biochemical and thermodynamic properties of 









D o m a i n Specific Labeled 
Multi-domain Protein 
Figure 1.7. Domain specific labeling of multi-domain proteins. 
Schematic representation of the domain specific incorporation of 7-
azatryptophan. Cys = Cysteine, 7 A W = 7-azatryptophan, 1 = Domain 1, 2 
=Domain 2, 27AW= 7 A W labeled Domain 2. 
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Crk Family of Signaling Adaptor Proteins 
The Crk family of signaling adaptor proteins are SH2 and SH3 domain 
containing proteins that have been implicated in cellular processes such 
as proliferation, adhesion and motility (Abassi and Vuori, 2002; Feller, 
2001; Hasegawa et al., 1996; KizakaKondoh et al., 1996; Lamorte et al., 
2002a; Lamorte et al., 2002b; Reddien and Horvitz, 2000; Zvara et al., 
2001). Alternative splicing of the c-crk gene yields two different translation 
products, Crk-I (~200 residues) (Figure1.8) and Crk-ll (~300 residues) 
(Figure 1.9). The Crk-ll isoform is the more widely expressed and contains 
a SH2 domain followed by two SH3 domains, whereas Crk-I lacks the C-
terminal SH3 domain (Matsuda et al., 1992; Reichman et al., 1992). Crk-I 
has been implicated in Philadelphia chromosome-positive leukemia (de 
Jong et al., 1995a; de Jong et al., 1995b) and is involved in the 
transformation of hematopoietic (Senechal et al., 1998) and fibroblast cells 
(Matsuda et al., 1992) (Figure 1.8). The related protein Crk-L has a similar 
architecture to Crk-ll (ten Hoeve et al., 1993). 
The primary role of Crk-ll as a scaffolding protein is to bring together 
signaling proteins that bind to the SH2 and SH3 modular interaction 
domains. Accordingly, the SH2 domain recognizes pY-X-X-P motifs and 
mediates interactions with several proteins such as p130cas, Cbl kinase 
and paxillin (de Jong et al., 1995a; Feller, 2001; Nojima et al., 1995; 
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Phosphorylated in Ph+ Leukemia 
Bcr/Abl 
Figure 1.8. D o m a i n architecture of the signaling adaptor protein, Crk-
I. (A) The primary sequence of the Crk-I protein. The S H 2 domain is 
highlighted in blue and the S H 3 domain in cyan. (B) The proteins that are 
known to interact with the S H 2 domain are shown in red. Crk-I is known to 
have a differential distribution in various tissue types in mice, though the 
functional significance of this distribution is unknown. 
between the two SH3 domains of Crk-ll contains the motif Y221-A-Q-P, 
which can be phosphorylated by the protein tyrosine kinase, c-Abl. This 
phosphorylation creates an intramolecular docking site for the Crk-ll S H 2 
domain (Feller et al., 1994). This triggers a structural change in the protein 
that is thought to regulate its function (Rosen et al., 1995). The Crk-ll S H 2 
domain is unique in that it contains a proline-rich insertion within a surface 
loop that serves as a ligand for the S H 3 domain of c-Abl (Anafi et al., 
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1996; Donaldson et al., 2002). The solution structure of the Crk-ll S H 2 
domain in complex with Abl-SH3 domain and the Crk-derived 
phosphotyrosine peptide has been determined and provides insights into 
the regulation of the two binding interactions involving the SH2 domain 
(Donaldson et al., 2002) (Figure 1.10). The SH2 domain binds to both 
























Figure 1.9. D o m a i n architecture of the signaling adaptor protein, Crk-
ll. (A) The primary sequence of the Crk-ll protein. The S H 2 domain is 
highlighted in blue, the nSH3 domain in cyan and the cSH3 domain in red. 
221Y is underlined. (B) The proteins interacting with the nSH2 and nSH3 
domains is shown along with the signaling events these interactions 
facilitate. Note that there are no functional protein-protein interactions 
attributed to the cSH3 domain. 
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unique poly-proilne loop, not present in other S H 2 domains that is 
recognized by the Abl SH3. The structure shows how the S H 2 domain of 
Crk can bring together distinct proteins via its two unique binding sites 
(Figure 1.10). The central SH3 domain of Crk-ll (hereafter referred to as 
nSH3) has also been well characterized at the structural (Wu et al., 1995) 
and biochemical (Camarero et al., 2001) levels. The nSH3 domain 
recognizes P-X-X-P-X-K sequences and has been shown to interact with 
several proteins including the guanine nucleotide exchange factor, C 3 G 
(Knudsen et al., 1994), DOCK180 (Matsuda et al., 1996) and c-Abl (Ren 
etal., 1994) (Figure 1.9). 
Poly-proline loop 
Crk-dervied Phosphotyrosine Peptide 
SH3 Domain of cAbl Kinase 
SH2 Domain of c-Crk 
Figure 1.10. Structure of the S H 2 domain of Crk (in green) in complex 
with S H 3 domain of cAbl (in cyan) and Crk-derived phosphotyrosine 
peptide (in red). 
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However, the biophysical properties of the nSH3 domain are poorly 
understood within the context of the full-length Crk protein. Therefore, one 
goal of this study is to gain a detailed understanding of how the folding 
and functional properties of the nSH3 domain are affected by the context 
of the multi-domain protein, Crk-I. 
Compared to the SH2 and nSH3 domains, the structure and function of 
the putative cSH3 domain of Crk-ll is poorly understood. The sequence of 
this region of the protein is highly conserved in organisms ranging from 
fruitfly to man, suggesting that the domain plays an important functional 
role (Figure 1.11). Indeed, point mutations or deletions in the cSH3 
domain are known to perturb a number of cellular processes, including 
proliferation (Hashimoto et al., 1998; KizakaKondoh et al., 1996), 
adhesion (Ogawa et al., 1994; Zvara et al., 2001) and endocytosis 
(Akakura et al., 2005; Sun et al., 2005). Moreover, overexpression of Crk-
I, which resembles the viral oncogene v-Crk (Mayer et al., 1988), is known 
Human PIYARVIQKR VPNAYDKTAL ALEVGELVKV TKINVSGQWE GECNGKRGHF PFTHVRLL 
Murine PIYARVIQKR VPNAYDKTAL ALEVGELVKV TKINVSGQWE GECNGKRGHF PFTHVRLL 
Tetraodon PVYARAIQKR VPNAYDKTAL ALEVGDRVKV TKINVNGQWE GECKGKRGHF PFTHVRLL 
Xenopus PVYAKAIQKR VPCAYDKTAL ALEVGDLVKV TRMNINGQWE GEVNGRKGLF PFTHVKII 
Drosophila PAYARVKQSR VPNAYDKTAL KLEIGDIIKV TKTNINGQWE GELNGKNGHF PFTHVEFV 
C.elegans PAKAKVTFDR VPNAYDPTQL RVKKGQTVLV TQKMSNGMYK AELDGQIGSV PHTYLRFT 
Figure 1.11. Sequence alignment of cSH3 domain of Crk-ll from 
several species. Conserved residues are highlighted in red, while 
residues conserved in all organisms, except C.elegans are in blue. 
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to transform fibroblasts in culture (Matsuda et al., 1992). These studies 
have led to the hypothesis that the cSH3 domain negatively regulates the 
function of Crk-ll (Feller, 2001; Ogawa et al., 1994). Further advancement 
of this model has been to a large extent frustrated by the inability to find 
classical P-X-X-P containing protein ligands for the cSH3 domain (Feller, 
2001). 
Although sequence alignment analyses strongly predict that the cSH3 
adopts the canonical SH3 fold (Larson and Davidson, 2000), many of the 
conserved aromatic residues that constitute the ligand-binding surface in 
the SH3 domain family are mutated to polar, typically non-aromatic 
residues in the cSH3 domain (Figure 1.1). This raises the possibility that 
the cSH3 domain does not bind typical P-X-X-P ligands or that it binds 
them with reduced affinity. The only documented interaction partner for the 
cSH3 domain is the nuclear exportin, Crm-1, which is believed to bind to a 
putative nuclear export sequence (NES, residues L256-V266) within the 
cSH3 domain (Smith et al., 2002). Interestingly, based on sequence 
alignment analysis (Larson and Davidson, 2000), the predicted NES forms 
part of the central p-barrel in the protein and, furthermore, two of the 
residues (V264 & V266) are expected to be in the hydrophobic core of the 
protein (Figure 1.1). Thus, the mechanism by which Crm-1 recognizes this 
NES in the context of the native cSH3 structure is unclear. Therefore, one 
aspect of this work has been to solve the solution structure and study the 
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folding properties of the cSH3 domain of Crk-ll. Progress towards utilizing 
domain specific labeling methods to label the cSH3 domain within the 
context of full-length Crk-ll will also be described. These studies should 
clarify the role of the cSH3 domain in regulating the function of the Crk-ll 
protein. 
24 
Objective of Thesis 
Outlined below are the specific aims of the thesis proposal, originally 
submitted in May, 2002. Significant progress towards each of these aims 
is reported herein. 
Specific aim 1 - Domain specific incorporation of 7AW into the SH3 
domain of Crk-I. This will be one of the first examples where a modular 
domain whose biophysical properties have been well characterized in 
isolation will be studied within its native context of the full-length protein. 
Specific aim 2 - Solve the solution structure and study the folding 
properties of the cSH3 domain of Crk-ll. Begin to understand the role of 
the cSH3 domain in modulating the function of Crk-ll and how this domain 
compares to other well-characterized SH3 domains from other proteins. 
Specific aim 3 - Begin to explore the role of cSH3 domain within full-
length Crk-ll. Domain specific labeling methods will be utilized to label the 
cSH3 domain within the context of Crk-ll. This should provide the 
important clues regarding the function of the cSH3 domain of Crk-ll. 
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Chapter 2 - Results 
Section 2.1 - Domain specific incorporation of 7AW into the SH3 
domain of Crk-I. 
The past few decades have seen incredible advances in our 
understanding of the biophysical properties of proteins. This has been 
possible largely due to studies on small isolated protein domains such as 
the SH3 domain. Arguably, the next step in extending our understanding 
of protein biophysics is to study how these domains behave within the 
native context of large multi-domain proteins. The major obstacle here is 
the lack of techniques that allow us to incorporate labels that inform us on 
the biophysical properties of a specific domain within a larger protein. 
Thus, a study was undertaken to address this issue. Significant progress 
towards this goal is described herein. 
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Design and synthesis of Crk-I with a 7 A W labeled SH3 domain 
Tryptophan analogues, such as 5-hydroxytryptophan, 
fluorotryptophans and 7-AW, allow the local environment of Trp residues 
in proteins to be studied using either NMR or fluorescence spectroscopies. 
In this study, we decided to replace the two Trp residues in the SH3 
domain of c-Crk-l, residues Trp169 and Trp170, with 7AW. As seen in the 
crystal structure of this domain in complex with a poly-Pro ligand from the 
protein, C3G (Figure 2.1 A), Trp169 is involved in ligand binding whereas 
Trp170 is an important component of the hydrophobic core of the protein 
(Wu et al., 1995). In both these Trp residues, the 7-position is solvent 
exposed in the unliganded form of the protein (Figure 2.1 B). This 
suggested to us that replacing these Trp residues with 7AW would not 
cause major perturbations in the structure of this SH3 domain. The effect 
of 7AW labeling on ligand binding was more of an open question. 
To make Crk-I with a 7AW labeled SH3 domain (hereafter referred to 
as Crk-I[SH37AW]) by EPL requires the generation of two recombinant 
protein building blocks; an a-thioester derivative encompassing the 
unlabeled SH2 domain and an N-terminal Cys containing 7AW labeled 
SH3 domain (hereafter referred to as SH37AW). Residues Gly124-Ser125, 
which lie within the short linker region (residues 119-133) between the two 
domains, were chosen as our ligation junction. The chemistry requires 
mutation of the serine to a cysteine, however, previous studies in our lab 
27 
Figure 2.1 Structure of the SH3 domain of Crk-I (pdb: 1CKA). (A) 
Expanded view of the structure of the SH3 domain of in complex with a 
poly-Pro peptide ligand (in orange) from the C3G protein. Trp 169, Trp 170 
and Val 184 are highlighted in blue. (B) Structure of the SH3 domain with 
surface rendering. The 7-positions of the two Trp residues are highlighted 
in red. 
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have shown that this mutation has no effect on the structure or function of 
the protein (Blaschke et al., 2000; Ottesen et al., 2003). 
The SH2 domain of c-Crk-l (residues M1-G124) was generated under 
non-labeling conditions as a Gyrase A intein fusion. The fusion protein 
was expressed in E.coli BL21 cells and purified from the soluble fraction 
by affinity chromatography. Thiolysis of the immobilized intein fusion 
yielded the desired SH2 a-thioester, which was then further purified by 
RP-HPLC. 
SH3 domain of Crk-I (residues C125 to G207) was expressed as a His-
tag fusion in an E.coliTrp auxotroph (E.coli CY15077(Yanofsky and Horn, 
1995)) grown in minimal media supplemented with 7AW (Schlesinger, 
1968). This procedure replaced the two Trp residues in the SH3 domain 
with 7AW (hereafter referred to as SH37AW). Following cell lysis, the 
desired fusion protein was purified from the soluble fraction by Ni2+-NTA 
affinity chromatography. The His-tag was then removed by cleavage with 
Factor Xa protease, which also exposed the N-terminal cysteine residue in 
SH37AW necessary for EPL. The cleaved protein was then purified by RP-
HPLC in an overall yield of ~1.5mg/L. Unlabeled SH3 domain (hereafter 
referred to as SH3W) was expressed under non-labeling conditions using 
rich media and purified as above. 
The recombinant building blocks in hand, Crk-I[SH37AW] was then 
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assembled via EPL. The ligation reaction was initiated by mixing the 
purified SH2 a-thioester and SH37AW domains in the presence of 6M 
Guanidinium chloride. Use of denaturating conditions was found to 
increase the yields in this system, however, in general the ligation 
approach can be performed under native conditions (Muir, 2003). The 
reaction was monitored by RP-HPLC, which indicated near complete 
conversion after 5 days (Figure 2.2A). The ligation product, Crk-I[SH37AW], 
was then purified by RP-HPLC and characterized by ESMS (Figure 2.2). 
Purified Crk-l[SH37AW]was refolded as described previously (Blaschke et 
al., 2000). 
To determine the extent of Trp replacement with 7AW, the purified 
SH37AW and SH3W domains were each cleaved with trypsin and the 
fragments analyzed by MALDI-TOF mass spectrometry. Of particular 
interest was the mass of an 18 amino acid fragment that contained both 
Trp residues in the protein (residues I161-K178). Trp and 7AW differ by 1 
Da, thus the SH37AW derived fragment should be 2 Da heavier than the 
corresponding SH3W fragment, assuming both Trp residues are replaced. 
Interpretation of the mass spectral data is complicated by the presence of 
the minor isotopes of C, H, N and O, which must be considered when 
calculating the incorporation efficiency (Senear et al., 2002). Figure 2.3 
shows the theoretical and observed isotope distributions in the mass 
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Figure 2.2. Semi-synthesis of Crk-I[SH37AW]. (A) R P - H P L C 
chromatogram of the crude mixture after ligation between the SH2 and the 
SH37AW domain to give Crk-I[SH37AW] after 5 days. The two starting 
materials and the product are indicated. The gradient was 3 0 % - 4 5 % 
Buffer B (90% acetonitrile/0.1% TFA in water) (B) The observed molecular 
mass calculated from the charged species seen in E S M S spectra of the 
ligation product, Crk-I[SH37AW]. Expected mass: 23048.5 Da. 
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comparison demonstrates that 7 A W labeling in SH37AW was highly 
efficient, & 9 3 % at both sites. 
(A) 
S H 3 w 
L . 
S H 3 7 A W 
1 I . . . 
2 2 1 5 m / z , a m u 2 2 3 0 2 2 1 5 m / z , a m u 2 2 3 0 
Theoretical O b s e r v e d 
Figure 2.3. Efficiency of 7AW incorporation. Calculated (assuming 
complete incorporation of 7 A W ) and observed isotope distributions of 
trypsin digest fragments of SH3W and SH37AW. SH3W peptide fragment: 
161IRDKPEEQWWNAEDSEGK178 (expected mass: 2217. 3Da) and SH37AW 
peptide fragment: 161IRDKPEEQ[7AW][7AW]NAEDSEGK178 (expected 
mass: 2219.3Da). (A) Theoretical isotope distributions of SH3W peptide 
and of SH37AW peptide (lower panel). (B) MALDI-TOF M S (reflectron) of 
SH3W peptide and of SH37AW peptide (lower panel) with 4-
hydroxycinnaminnic acid (4HCCA) as the matrix. 
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Initially, the SH37AW domain was also expressed as a Gyrase A intein 
fusion. This intein contains a single Trp residue, which was also replaced 
by 7 A W in the labeling procedure. Our studies indicate that replacement of 
the Trp residue in Gyrase A intein with 7 A W has no effect on the 
functioning of the intein; thiolysis of the 7AW-containing fusion protein 
proceeded to a similar degree as for the wild-type intein (Figure 2.4). 
Thus, w e can also generate 7 A W labeled proteins with C-terminal 
thioesters. Importantly, this will allow us to label any part of the protein and 
apply EPL to its fullest extent. 














Figure 2.4. Cleavage of 7 A W labeled Gyrase A intein (GyrA) with DTT. 
The SH3-GyrA intein fusion protein labeled with 7 A W ([SH3-GyrA]7AW, 
lanes 1 and 2) and the unlabeled intein fusion protein ([SH3-GyrA]w, lanes 
3 and 4) were incubated for one hour either with DTT (lanes 2 and 4) or 
without DTT (lanes 1 and 3) and analyzed by SDS-PAGE. Cleavage of the 
intein fusion proteins with DTT yielded SH37AW, 7 A W labeled GyrA 
(GyrA7AW), SH3W and unlabeled GyrA (GyrAw). Coomassie stained SDS-
P A G E is shown above. 
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Structural characterization of SH3W, SH37AW and Crk-I[SH37AW] 
A combination of fluorescence, C D and N M R spectroscopies were 
used to gauge the affect of 7 A W labeling on the structural and folding 
properties of the Crk-I SH3 domain. The fluorescence emission spectra of 
SH3W, SH37AW and Crk-I[SH37AW] upon excitation at 310 nm are shown in 
Figure 2.5. SH37AW and Crk-I[SH37AW] exhibited broad emission spectra 
with maxima at 388 nm and 377 nm, respectively, whereas SH3W was 
essentially non-fluorescent under these excitation conditions. Thus, as 
expected, the 7 A W labeled SH3 domain can be selectively excited in the 
presence of Trp. The slight difference in the emission spectra of SH37AW 
and Crk-I[SH37AW] suggests that 7 A W sees different local environments 
depending on whether or not the SH3 domain is in the context of the Crk-I. 
The secondary structures of the SH3W and SH37AW domains were 
studied by far-UV C D spectroscopy. Consistent with a previous report 
from our group (Camarero et al., 2001), the C D spectrum of SH3W 
exhibited minima at 203 nm and 229 nm and a maxima at 219 nm (Figure 
2.6). These unusual spectral features have been seen in other SH3 
domains (Viguera et al., 1995) and are likely due to aromatic contributions 
(Camarero et al., 2001; Manning and Woody, 1989). The C D spectrum of 
SH37AW differs slightly from that of SH3W (Figure 2.6), however, it does so 
in the regions attributed to aromatic contributions (the minimum at 229 nm 
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Figure 2.5. Fluorescence emission spectra of SH3W, SH37AWand Crk-
1[SH37AW]. The excitation wavelength was 310 nm. SH3W has virtually no 
fluorescence emission when excited at this wavelength. 
possibly reflecting the differences in the aromaticity of 7AW vs. Trp. 
Importantly, the CD spectra of SH3W and SH37AW are otherwise similar, 
indicating that 7AW incorporation does not cause major structural changes 
in the domain. Furthermore, the mid-point (TJ of temperature 
denaturation of SH3W and SH37AWwas determined by following the change 
in the CD signal at 220 nm (Figure 2.7). Thermal denaturation of SH3W 
and SH37AW showed 2-state behavior and was reversible. The Tm of SH3W 
and SH37AW were similar (332.2 ± 0.4 and 330.0 ± 0.6 K, respectively), 










Figure 2.6. Far UV C D spectra of SH3W and SH37AW. The C D spectra of 
the two SH3 domains differs in the region (around 230 nm) attributed to 











2 8 0 
SH3yy 
SH37AW 
3 6 0 3 0 0 3 2 0 3 4 0 
Temperature (K) 
Figure 2.7. Thermal denaturation curves of SH3W and SH37AW. C D 
signal was recorded at 220nm. Thermal unfolding of both domains was 
found to be completely reversible. 
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Homonuclear 1H N M R spectroscopy was used to further investigate 
the effects of 7 A W incorporation (Figure 2.8 and 2.9). The N O E S Y spectra 
of SH3W and SH37AW are very similar (Figure 2.9). The a-fingerprint 
regions of both spectra are well dispersed and indicative of a well-defined 
protein fold with significant contribution from p-sheets. Additional 
diagnostic features of a native fold in the SH3W and SH37AW domains are 
the presence of N O E S Y cross-peaks between Trp170 and Val184and 
upfield chemical shifts at around -0.85 ppm for y-methyl protons of Val184 
(Figure 2.8). These result from the side-chain of Val184 being tightly 
packed against the indole ring of Trp170 within the hydrophobic core of 
the protein (Figure 2.1 A) (Wu et al., 1995). Thus, the C D and homonuclear 
N M R data suggests that the SH3W and SH37AW domains share a common 
fold and that the incorporation of 7 A W is well tolerated. 
Figure 2.8. Overlaid of 1H N M R spectra of SH3W (in gray) and SH37AW 
(in black). The spectra were acquired on a 400 M H z spectrometer. The 
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Figure 2.9. A m i d e and aromatic region of the 1H N O E S Y spectra of 
SH3W and SH37AW. The spectra were acquired on a 500 M H z 
spectrometer. 
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Ligand binding properties of SH3W and SH37AW and Crk-I[SH37AW] 
The ligand binding properties of SH3W, SH37AW and Crk-I[SH37AW] 
were studied using a fluorescence based binding assay. The ligand used 
in these experiments was a fluorescein-containing analogue of a proline-
rich peptide derived from the protein, C3G. The binding isotherm was 
followed either by the change in Trp fluorescence, in the case of SH3W, or 
by the change in 7 A W fluorescence, in the case of SH37AW and Crk-
l[SH37AW], as a function of added ligand to the protein (Figure 2.10). As 
shown in Table 2.1, these studies indicate that there are no significant 
differences in the ligand binding properties of SH3W and SH37AW. Thus, 
replacement of the two Trp residues in the SH3 domain by 7 A W appears 
to be a silent mutation in terms of the functional properties of the 
molecule. This finding answers a key question posed at the outset of our 
studies, namely whether incorporation of the aza group at the 7-position of 
the indole ring of Trp169, which is ideally positioned to contact the ligand, 
would perturb the ligand binding properties of the protein. The data 
summarized in Table 2.1 also reveals that the ligand binding activity of the 
SH3 domain does not change dramatically in the context of Crk-I. 
However, it should be stressed that a small peptide ligand was used in 
these studies and not a native protein ligand. 
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Figure 2.10. Binding isotherms of poly-Pro ligand from C 3 G to SH3W, 
SH37AW and Crk-I[SH37AW], as determined by change in either tryptophan 
or 7 A W fluorescence. The solid curve represents the best fit for equation 1 
(page 113). Shown here is a one representative curve out of three 
experiments. 
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Table 2.1. Dissociation Constants of the Various SH3 Constructs for 









22.5 ± 1.3 
aAII experiments were performed at 25 °C in 20 m M sodium phosphate, 
100 m M sodium chloride, pH 7.0. The numbers following ± symbol 
represent the standard errors to the fit. 
Equilibrium stabilities of SH2, SH3W and SH37AW and Crk-I[SH37AW] 
The equilibrium stabilities of the SH2, SH3W and SH37AW domains 
and Crk-I[SH37AW] were determined using the change in fluorescence of 
either Trp or 7 A W residues upon the addition of chemical denaturants. All 
the constructs exhibited well-defined unfolding curves (Figure 2.11) and 
from this we elucidated the equilibrium stabilities (AG°H2o) and m values for 
all the proteins (Table 2.2). The equilibrium stabilities of SH3W matched 
closely with the published values for this domain (Camarero et al., 2001). 
The AG°H20 value for the SH2 domain reveals that this protein is 
unusually stable (Table 2.2) (Scalley-Kim et al., 2003; Tzeng et al., 2000). 
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The estimated values of AG°H2o for SH3W and SH37AW, are similar to that of 
other SH3 domains (Grantcharova and Baker, 1997; Lim et al., 1994; 
Viguera et al., 1994) and to each other. The fact that the SH3W and 
SH37AW domains have similar stabilities validates the labeling procedure 
and provides further evidence that the labeled and the unlabeled domains 
are comparable. Analysis of the AG°H2o values reveals that the SH3 
domain when in the context of c-Crk-l has a similar stability to the isolated 
domain. Thus, equilibrium stability measurements do not reveal any major 
change in the thermodynamic properties of the SH3 domain in isolation 
versus in c-Crk-l. This represents the first direct comparison of the stability 
of an isolated SH3 domain to its stability when incorporated in an intact 
multi-domain protein. 







AG' 'H20(kcal mol"1) 
8.1 ±0.4 
3.9 ± 0.4 
3.2 ± 0.3 
3.7 ±0.4 
m (kcal mol1 M1) 
3.2 ±0.1 
2.6 ± 0.2 
2.3 ±0.1 
2.5 ± 0.2 
aAII experiments were performed at 25 °C in 20 m M sodium phosphate, 
100 m M sodium chloride, pH 7.0. The numbers following ± symbol 
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Figure 2.11. Chemical denaturation of SH3W, SH37AW, S H 2 domain and 
Crk-I[SH37AW], followed by fluorescence spectroscopy. The solid curve 
represents the best fit for eqs. 3-4. 
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Section 2.2 -- The solution structure and folding properties of the 
cSH3 domain of Crk-ll. 
The C-terminal SH3 domain of Crk-ll is unique among SH3 domains in 
that all attempts to find a poly-proline ligand for this domain have failed. 
This has deepened the mystery surrounding the role that this domain 
plays in regulating the function of Crk-ll. As a first step towards 
understanding the role of the cSH3 in regulating Crk-ll function, a series of 
structural and biophysical studies on the isolated domain were carried out. 
Significant progress towards this goal is described herein. These studies 
also offer some insight into the likely structural and thermodynamic 
consequences of point mutations in the cSH3 domain that are known to 
deregulate Crk-ll function. 
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Solution Structure of the Crk-ll cSH3 domain 
Sequence homology suggests that the cSH3 domain of Crk-ll 
extends from P237 to L294 (Figure 1.1). However, sequence alignment 
analysis lacks the ability to predict domain boundaries with absolute 
certainty. Indeed, it has been observed in the nSH3 domain of Crk-ll that 
minor truncations at the N-terminus can have serious consequences on 
the folding of the domain (Camarero et al., 2001). Therefore, a slightly 
longer cSH3 domain construct was used in our studies, extending from 
L230 to S304. The cSH3 domain was over expressed in E.coli as a His-
tag fusion linked via a Tev protease cleavage site. Following affinity 
purification, the tag was cleaved and the cSH3 domain purified by ion 
exchange chromatography (Note: Use of the Tev protease leaves a 
glycine residue at the N-terminus of the protein). The purified cSH3 
domain was exchanged into the NMR buffer (see methods) and 
concentrated to typically 0.5 mM for NMR analysis. An initial estimate of 
the rotational diffusion tensor was made using the 15N relaxation rates R^ 
R2 and 15N-1H NOE values after removing the overlapping residues and 
those that had potential chemical exchange contribution. The best model 
that fits the NMR data was an isotropic model with the overall correlation 
time (xc) of 5.27 ns. This strongly suggests that the cSH3 domain behaves 
as a monomer in solution. 
Uniformly 15N and 13C labeled cSH3 domain was used to obtain the 
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main-chain and side-chain assignments of the 1H, 15N and 13C resonances 
using a standard set of triple resonance 3D experiments (Cavanagh, 
1996) (see Appendix 1 for assignments). All backbone assignments were 
made with the exception of the amide nitrogen and amide proton 
resonances of L230, V247, and V271 (Figure 2.12). There are five proline 
residues in the cSH3 domain and they are in trans configuration based on 
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Figure 2.12. Assigned H S Q C spectrum of cSH3 domain. The spectrum 
was assigned using a set of standard 3D NMR experiments. The side 
chain assignments are denoted as 'SC. 
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An initial assessment of the cSH3 secondary structure was made using 
the deviations of assigned chemical shifts from random coil (Wishart and 
Sykes, 1994) (Figure 2.13). This indicates that the domain consists of 
five p -strands as seen for other SH3 domains. The steady state 15N-[1H] 
heteronuclear overhauser effect (NOE) indicates that, except for residues 
at the N-terminus (L230-G236) and the C-terminus (L294-S304), the 
domain is well ordered with relatively little flexibility in the intervening 
sequence compared to the termini of the domain (Figure 2.14). Therefore 
residues L230 to N235 at the N-terminus and residues P299 to S304 at 
the C-terminus were excluded from the final structure calculation. 
All NOE cross peaks (both assigned and unassigned) in the 15N 
NOESY-HSQC and 13C NOESY-HSQC spectra were used by ARIA/CNS. 
The final set of structure calculations were done using a total of 1074 
unambiguous restraints (538 intraresidue, 238 sequential, 91 short range, 
17 medium range and 190 long range). Furthermore, 291 ambiguous 
restraints were also incorporated in the structure calculations. In addition, 
96 dihedral (49 <j> and 47 i|j) and 46 hydrogen bond restraints were used in 
the structure calculations. There was no increase of the target function 
upon adding the hydrogen bond restraints, thereby indicating that these 
restraints were consistent with the distance restraints. Structural statistics 
and analysis are given in Table 2.3. 
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Figure 2.13. Chemical shift indexing (CSI) of the 13C, 13C„and 15N 
assignments of the cSH3 domain. The assignments were compared to 
a database to predict the secondary structure of the domain. 
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Figure 2.14. Hetero-nuclear N O E measurements for the cSH3 domain. 
Residues with N O E values 0.7 or more are expected to be well ordered 
and residues with N O E values less than 0.7 are expected to be in flexible 
loops or linker regions (Kay et al., 1989). 
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Table 2.3. N M R restraints and structural statistics for the 20 best 
structures. 
Restraints and statistics 
Total number of restraints 








Dihedral angle restraints 
Hydrogen bond restraints 
Structure Statistics 
N O E violations > 0.5A 
Dihedral violations > 5° 
R M S D from average structure 
All residues (236-298) 
Backbone (N, CaJ C) (A) 
Heavy atoms (A) 
Ramachandran Statistics 
Most favored region (%) 
Additionally allowed (%) 






















The 20 calculated structures with the lowest target function values are 
superimposed in Figure 2.15A. These structures exhibit no distance and 
dihedral restraint violations greater than 0.5 A and 5° respectively. The 
structure ensemble has average pairwise atomic rmsd of 0.68 ± 0.17 A for 
backbone residues and 1.39 ± 0.21 A for all heavy atom residues. The 
root mean square deviation of the ensemble with respect to the average 
structure was 0.48 ± 0.12 A for the main-chain and 0.99 ± 0.12 A for the 
heavy atoms. The quality of the structures were analyzed using 
PROCHECK and WHATIF. 74.8% of all non-glycine and non-proline 
residues are in the most favored regions of the G>-ip space, with none of 
the residues in the disallowed regions (Table 2.3). The three-dimensional 
structure of the Crk-ll cSH3 domain has five p-strands (residues (31=1238-
V242, p2=E262-K268, p3=W275-C279, p4=K282-F286 and p5=R292-
L294) organized in an anti-parallel p-barrel structure (Figure 2.15B). The 
secondary structure of the cSH3 domain is similar to that determined by 
homology modeling (Reichman et al., 2005). Analogous to all other SH3 
domains, the stands are connected by a series of loops, namely; residues 
I243 to G261 (by convention the RT-loop), residues I269 to Q274 (the n-
Src loop) and residues N280 to G281 (the distal loop). The last two p-
strands are connected by a short 310-helix from F288 to H290. 
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Figure 2.15. Solution structure of the cSH3 domain. The structures 
were drawn using M O L M O L (Koradi et al., 1996). (A) The 20 lowest 
energy structures are superimposed, p-strands are shown in red and the 
310-helix is shown in cyan. (B) Ribbon diagram of the cSH3 domain. 
51 
The cSH3 domain adopts the canonical SH3 domain fold. For 
example, the backbone rmsd of the cSH3 domain obtained after structural 
alignment to the nSH3 domain (1cka) of Crk-ll is 1.29 A (Figure 2.16). 
Consistent with other SH3 domains, the cSH3 domain possesses a 
compact hydrophobic core comprising several residues that collectively 
bury 2249 A2 of residue surface area, which is similar to that seen in other 
SH3 domains (e.g. nSH3 = 2355 A2). The hydrophobic core also includes 
L256, L258, V264 and V266, that are a part of the putative NES in the 
cSH3 domain (Smith et al., 2002) (Figure 2.17). Of note, is the presence of 
the valine residue at position 242, within the first p-strand. The 
corresponding residue in other SH3 domains is almost always an alanine, 
indeed its conservation is ~75% (Larson and Davidson, 2000). The extra 
volume associated with having the branched valine residue in the core 
seems to be accommodated, at least in part, by the presence of A240 that 
is usually a slightly larger hydrophobic residue in other SH3 domains. This 
reorganization underscores the plasticity of the hydrophobic core of SH3 
domains (Northey et al., 2002). 
The ligand-binding surface of SH3 domains is characterized by several 
conserved aromatic residues (Figure 1.1). Most of these conserved 
residues are mutated to more polar residues in the cSH3 domain, 
specifically, Q244, R246, Q274, and H290 (Figure 2.18A). Thus, a 
question at the outset of this study was whether the 
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cSH3-nSH3 cSH3-Csk SH3 
cSH3-Sem5 SH3 cSH3-cAbl SH3 
Figure 2.16. Structural alignment of the cSH3 domain with other SH3 
domains. The cSH3 domain is shown in cyan. The nSH3 domain of Crk-ll 
is shown in yellow, pdb code:1cka (rmsd= 1.29 A). Csk SH3 domain is 
shown in red, pdb code:1jeg (rmsd= 1.24 A). cAbl SH3 domain is shown in 
blue, pdb code:1abo (rmsd= 1.36 A). S e m 5 SH3 domain is shown in 
magenta, pdb code:1sem (rmsd= 1.28 A). 
conserved aromatic residues on the ligand-binding surface have been 
replaced with non-conserved aromatic residues or is the surface indeed 
more polar. Based on structural alignment, the residues that form a 
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canonical ligand-binding pocket in the c S H 3 domain are Q 2 4 4 , G 2 7 3 , 
Q274, P287, T289 and H290 (Figure 2.18B). These residues are exposed 
to the bulk solvent in the structure forming a contiguous surface on the 
c S H 3 domain that corresponds to the ligand binding surface on most other 
S H 3 domains (Figure 2.18B). S o m e of these residues also contribute to 
m a k e the surface of the c S H 3 domain basic in nature (Figure 2.19). The 
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Figure 2.17. Surface representation of the putative N E S (highlighted in 
blue and cyan) in the cSH3 domain. The residues in cyan are part of the 
hydrophobic core of the domain and are indicated. 
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Figure 2.18. The ligand binding pocket of the cSH3 domain. (A) The 
ligand and the aromatic residues (in green) that interact in the nSH3 
domain are shown. Superimposed is the canonical ligand binding pocket 
of the cSH3 domain and the corresponding residues (in red) lining the 
pocket in the cSH3 domain. (B) The residues that form the entire 
canonical ligand binding pocket in the cSH3 domain are shown in surface 
representation and are indicated. 
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Figure 2.19. Surface charge distribution of the nSH3 domain (top 
panel, 1cka) and the cSH3 domain (bottom panel). The electrostatic 
surface representation of the two structures was drawn using Swisspdb 
viewer (Guex and Peitsch, 1997). The poly-proline ligand is shown for the 
nSH3 domain. 
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Folding Properties of the cSH3 domain of Crk-ll 
The change in the fluorescence signal of the tryptophan residue 
upon addition of chemical denaturants was used to determine the 
equilibrium stability of the cSH3 domain. The structure shows that this 
tryptophan residue is buried in the hydrophobic core of the cSH3 domain. 
The tryptophan packs against several residues (1238, V266, F288, V291 
and L293) and results in the burial of 1117 A2 hydrophobic surface area 
(Figure 2.20). The unfolding of the cSH3 domain exposes this buried 
tryptophan to bulk solvent. This results in a robust change in the 
fluorescence intensity upon the addition of chemical denaturation; a 3-fold 
decrease at 340 nm. The domain exhibited a well-defined unfolding curve 
from which we elucidated the stability (AG°H20) and m value for the cSH3 
domain using equation 3 and 4 (Figure 2.21, Table 2.4). 
Figure 2.20. The packing of W 2 7 5 into the hydrophobic core of the 
cSH3 domain. The residues that pack along with W 2 7 5 are indicated. 
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Equilibrium denaturation measurements show that the cSH3 domain 
folds in a reversible two-state manner. The equilibrium stability of the 
cSH3 domain was found to be 3.3 kcal mol"1, which is similar to that 
observed for other SH3 domains (Camarero et al., 2001; Grantcharova 
and Baker, 1997; Guijarro et al., 1998; Plaxco et al., 1998; Viguera et al., 
1994) (Table 2.4). The m-value, which is proportional to the change in 
solvent exposed hydrophobic surface area upon unfolding, is 0.66 kcal 
mol"1 M"1, which is slightly lower than that seen for other SH3 domains 
















Figure 2.21. Equilibrium denaturation of the cSH3 domain. 
Fluorescence intensity was recorded as a function of urea concentration. 
The solid line represents the best fit to eqs. 3-4. 
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The folding kinetics of the cSH3 domain was measured using 
fluorescence-detected stopped-flow experiments (Figure 2.22). 
Interestingly, the data can be fit to a single exponential decay, i.e., the 
refolding of the cSH3 domain is monophasic. This was surprising since 
the cSH3 domain contains five proline residues, which was expected to 
result in a slow-phase in the folding amplitude due to proline cis-trans 
isomerization as has been observed in most other SH3 domains 
(Camarero et al., 2001; Grantcharova and Baker, 1997; Guijarro et al., 
1998; Viguera et al., 1994). The absence of the slow phase in the folding 
Table 2.4. Folding thermodynamics and kinetics for the cSH3 
domain3 
Equilibrium Thermodynamics 
AG°H20 (kcal mol"1) 




AG°kin (kcal mol"1) 
nryvalue (kcal mol"1 M"1) 
mu-value (kcal mol"1 M"1) 
mtota|-value (kcal mol"1 M"1) 
3.3 ± 0.3 
0.7 ±0.1 
82.6 ± 2.9 
0.2 ± 0.03 
3.7 
0.6 ± 0.01 
0.2 ± 0.01 
0.8 
aAII experiments were performed at 25 °C in 20 m M sodium phosphate 
and 100 m M sodium chloride at pH 7.2. The numbers following the ± 
represent standard errors to the fit. 
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Figure 2.22. Folding kinetics of the cSH3 domain. Chevron plot of the 
natural log of the observed rate constant as a function of urea 
concentration. The solid line represents the best fit to eq. 5. 
amplitude indicates either that the proline residues are all in the trans 
configuration in the unfolded state or that the observed tryptophan 
fluorescence is unaffected by the nature of proline isomerization. This 
situation is reminiscent of the Fyn SH3 domain, which also exhibits 
monophasic refolding behavior despite containing two proline residues 
that are trans in the native state (Plaxco et al., 1998). Figure 2.22 shows 
the plot of the natural logarithm of the observed rate constant, kobs versus 
urea concentration. The chevron plots show a classic V-shape curve, as 
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expected for a protein that folds in a two-state manner. At low 
denaturation concentration we did not observe any rollover, i.e., deviation 
from linearity. The AG0 value and the m-value calculated from the kinetic 
measurements, 3.66 kcal mol"1 and 0.71 kcal mol'1 M"\ are in good 
agreement with the equilibrium measurements (Table 2.4). The ratio of m, 
/ mtotai, denoted pT, is a measure of the relative compactness of the 
transition state. The calculated value for cSH3 is 0.78 indicating a 
compact transition state ensemble. This value is similar to that observed 
with other SH3 domains. For example, the value for nSH3 domain of Crk-ll 
is 0.71 (Camarero et al., 2001). The kinetic data is also consistent with an 
apparent two-state folding model. 
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Section 2.3 - The functional role of the cSH3 domain within full-
length Crk-ll. 
Several lines of evidence point to an important role of the C-terminal 
SH3 domain (cSH3) in regulating the function of Crk-ll. The structure 
offers us important clues to the function of the cSH3 domain and explains 
the results of some of the mutational studies performed on Crk-ll. 
However, understanding the detailed nature of the functional interplay 
between the cSH3 domain and the rest of Crk-ll requires the use of 
domain specific labeling. In this section, progress towards that goal will be 
described. 
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Design and synthesis of Crk-ll with a cSH3 domain specific label 
To explore the role of the cSH3 domain within Crk-ll, two domain 
specific labeling strategies were employed. The first strategy was to 
incorporate 7 A W specifically into the cSH3 domain and utilize 
fluorescence spectroscopy to study the domain. There is a single Trp 
residue in the cSH3 domain (W275), which is buried in the hydrophobic 
core. As can be seen from the structure, the 7-position of Trp 275 is also 
in the hydrophobic core of the protein (Figure 2.23). This suggests that 
replacing this residue with 7 A W might perturb the structure of the cSH3 
domain. The extent of this perturbation was an open question. With this in 
mind a second strategy was undertaken. In this approach the cSH3 
domain was segmentally labeled with stable isotopes and utilize N M R 
spectroscopy. 
Figure 2.23. Structure of the cSH3 domain of Crk-ll with surface 
rendering showing Trp 275 (in blue). The 7-position is highlighted in red. 
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To make Crk-ll with a 7 A W or isotope labeled cSH3 domain (hereafter 
referred to as Crk-Il[lcSH37AW] and Crk-ll[lcSH315N]) by EPL requires the 
generation of two recombinant protein building blocks; an a-thioester 
derivative encompassing the unlabeled SH2 domain and N-terminal SH3 
domain (nSH3) and an N-terminal Cys containing labeled cSH3 domain. 
Based on previous studies in our lab (Blaschke et al., 2000; Ottesen et al., 
2003), Gly207-Ser208, which lies in the linker region between the two SH3 
domains, was chosen as the ligation site. Ser208 was mutated to a 
cysteine, which is required for the ligation chemistry. Based on previous 
work, this does not have any effect on the structure or function of the 
protein, at least in vitro (Blaschke et al., 2000; Ottesen et al., 2003). 
The construct encompassing the SH2 domain and the nSH3 domain, 
which is the same as Crk-I (residues M1- G207), was made under non-
labeling conditions as a Gyrase A intein fusion. The fusion protein was 
expressed in E.coli BL21 cells and purified from the soluble fraction by 
affinity chromatography. Thiolysis of the immobilized intein fusion yielded 
the desired Crk-I a-thioester, which was then further purified by RP-HPLC. 
The cSH3 domain (C208-S304, which includes the linker region C208-
P229) was expressed as a His-tag fusion in E.coli BL21 cells grown in 
minimal media supplemented with 15NH4CI to generate a uniformly 15N 
labeled domain (hereafter referred to as lcSH315N). The 7AW labeled cSH3 
domain (hereafter referred to as lcSH37AW) was also expressed as a His-
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tag fusion protein in E.coliTrp auxotrophic cells (Muralidharan et al., 2004) 
grown in minimal media supplemented with 7 A W . This replaced the single 
Trp residue in the cSH3 domain (W275) with 7 A W . To gauge the effect of 
7 A W incorporation into the c S H 3 domain, a shorter construct (L230-
S304), previously used to solve its structure, was also labeled with 7 A W 
(hereafter referred to as cSH37AW), which was purified as in section 2.2. 
Following cell lysis, the desired fusion proteins were purified from the 
soluble fraction by Ni2+-NTA affinity chromatography. The His-tags were 
then removed by cleavage with Factor Xa protease, which also exposed 
the N-terminal cysteine residue in the labeled cSH3 domains necessary for 
EPL. The cleaved proteins were then purified by RP-HPLC with an overall 
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Figure 2.24. E S M S characterization of lcSH37AW and lcSH315N. (A) The 
reconstructed mass spectrum of lcSH37AW. The indicated mass was 
calculated from the charged species seen in the parent E S M S spectrum. 
Expected mass: 10688.0 Da. (B) The reconstructed mass spectrum of 
lcSH3!5N. The indicated mass was calculated from the charged species 
seen in the parent E S M S spectrum. Expected mass: 10822.0 Da. 
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Crk-ll with the cSH3 domain specifically labeled with either 15N or 7 A W 
was assembled via EPL by mixing purified Crk-I a-thioester with the 
labeled cSH3 domain (Figure 2.25). Both reactions were carried out in the 
presence of 6M guanidinium chloride. The reactions were monitored by 
RP-HPLC and SDS-PAGE and were both near completion after 7 days 
(Figure 2.26 and 2.27). The ligation products, Crk-ll[lcSH37AW] (Figure 
2.26) and Crk-ll[lcSH315N] (Figure 2.27), were purified by RP-HPLC and 
characterized by ESMS. The lyophilized ligated proteins were dissolved in 
buffer containing 6 M guanidinium chloride and refolded as described 
previously (Blaschke et al., 2000). 
Recombinant Expression Recombinant Expression 
r \ ^ D 
Native Chemical 
Ligation 
Crk-ll[lcSH37AW] / Crk-ll[lcSH315N] 
Segmentally Labeled c S H 3 Domain Within Crk-ll 
Figure 2.25. Domain specific incorporation of labels into the cSH3 
domain of Crk-ll. Schematic representation of the strategy to label the 
cSH3 domain within full-length Crk-ll. 
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Figure 2.26. Semi-synthesis of Crk-ll[lcSH37AW]. (A) S D S - P A G E 
analysis of the crude mixture after ligation between Crk-I and lcSH37AW to 
give Crk-ll[lcSH37AW] after 3 days. The reaction was allowed to proceed for 
7 days after which it was near completion based on HPLC. The two 
starting materials and the ligation product are indicated. (B) The 
reconstructed mass spectrum of the ligation product. The indicated mass 
was calculated from the charged species seen in the parent E S M S 
spectrum. Expected mass: 33773.6 Da. 
(A) 
lcSH3,SN 
(B) 33851.0 ±5.6 
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Figure 2.27. Semi-synthesis of Crk-ll[lcSH315N]. (A) R P - H P L C 
chromatogram of the crude mixture after ligation between Crk-I and 
lcSH315N domain to give Crk-ll[lcSH315N] after 5 days. The two starting 
materials and the product are indicated. The gradient was 3 8 % - 4 2 % buffer 
B (90% acetonitrile/0.1% TFA in water) (B) The reconstructed mass 
spectrum of the ligation product. The indicated mass was calculated from 
the charged species seen in parent E S M S spectrum. Expected mass: 
33907.6 Da (assuming complete incorporation of 15N). 
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Structural and thermodynamic characterization of cSH37AW and Crk-
M[lcSH37AW] 
The effect of 7AW incorporation into the cSH3 domain was 
investigated using a combination of NMR and fluorescence 
spectroscopies. The NOESY spectra of unlabeled cSH3 domain and 
cSH37AW are similar (Figure 2.28). The a-fingerprint regions of both 
spectra are well dispersed and indicative of a well-defined protein fold with 
significant contribution from p-sheets. This suggests that the incorporation 
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Figure 2.28. Amide and aromatic region of 1H NOESY spectra of cSH3 
(in black) and cSH37AW (in red) domains. The spectra were acquired on a 
700 MHz spectrometer. 
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The equilibrium stability of cSH37AW was determined using the change 
in 7 A W fluorescence as a function of increasing denaturant concentration. 
The cSH37AW domain exhibited a well-defined unfolding curve from which 
the equilibrium stability (AG°H2o) and tn© m-value of this domain were 
elucidated (Table 2.5 and Figure 2.29). These measurements show that 
the incorporation of 7 A W into the cSH3 domain destabilizes the domain by 
~ 1 kcal mol"1. Thus, even though the overall structure of the cSH3 domain 
is not affected by the incorporation of 7AW, there is an energetic cost 
associated with the incorporation. This is presumably due to the fact that 
the Trp residue in the cSH3 domain is buried in the hydrophobic core of 
the domain. The burial of the polar 7-aza group in 7 A W in the hydrophobic 
core probably causes the destabilization of cSH37AW compared to the 
unlabeled cSH3 domain. 





AG°H20 (kcal mol"1) 
3.3 ± 0.3 
2.5 ± 0.4 
m (kcal mol"1 M1) 
0.7 ±0.1 
0.5 ±0.1 
aAII experiments were performed at 25 °C in 20 m M sodium phosphate, 
100 m M sodium chloride, pH 7.0. The numbers following ± symbol 
represent the standard errors to the fit. 
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Figure 2.29. Chemical denaturation of unlabeled cSH3 domain and 
cSH37AW followed by fluorescence spectroscopy. The solid curve 
represents the best fit for eqs. 3-4. 
The measurement of the equilibrium stability of Crk-ll[lcSH37AW] was 
also attempted by measuring the change in 7 A W fluorescence as a 
function of changing denaturant concentration. However, the 7 A W labeled 
cSH3 domain did not exhibit a well-defined unfolding curve and that 
precluded any estimation of the equilibrium stability of the cSH3 domain 
within the context of Crk-ll (Figure 2.30). 
The fluorescence emission spectra of Crk-ll[lcSH37AW] is broader than 
that of cSH37AW (Figure 2.31). The emission maxima of cSH37AW is at 371 
nm while that of Crk-ll[lcSH37AW] is at 377 nm. At these maxima, the 
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fluorescence intensity of Crk-ll[lcSH37AW] is ~ 2 2 % less than that of 
cSH37AW. This strongly suggests that 7AW is present in a different local 
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Figure 2.30. T h e change in 7 A W fluorescence of Crk-ll[lcSH37AW] as a 
function of increasing amount of denaturant. This data could not be fit 
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Figure 2.31. Fluorescence emission spectra of cSH37AW and Crk-
M[lcSH37AW]. The excitation wavelength was 310 nm. The concentrations 
of both proteins were 1 liM (see methods for concentration determination). 
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Structural characterization of lcSH315N and Crk-ll[lcSH315N] 
Previous attempts to find a PXXP ligand for the cSH3 domain have 
failed (Feller, 2001). This has led to the hypothesis that the cSH3 domain 
of Crk-ll regulates the function of the protein via an intramolecular 
interaction (Feller, 2001; Ogawa et al., 1994). The Crk-ll protein has two 
proline rich regions, which could interact with the cSH3 domain in an 
intrasteric fashion (Figure 2.32). To investigate the possibility of an 
intramolecular interaction, segmental isotopic labeling was utilized, where 
the cSH3 domain was labeled within the context of full-length Crk-ll. N M R 
spectroscopy was utilized to study the changes in the structure of the 






Figure 2.32. Possible intramolecular binding sites of the cSH3 
domain within Crk-ll. Shown are just two possible binding interactions, 
assuming a canonical PXXP-type interaction. However, it is possible that 
the cSH3 domain participates in non-canonical interactions. cAbl 
phosphorylates Crk-ll on Y221 (highlighted in red). 
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The H S Q C spectrum of lcSH315N is shown in Figure 2.33. Overlaid is 
the HSQC spectrum of the cSH3 domain without the linker region that was 
used to solve the solution solution structure of the domain. The difference 
between these two cSH3 domain constructs is that lcSH3 has an 
additional 22 residues (C208-P229) from the linker region between the two 
SH3 domains of Crk-ll. The comparison shows that there is some minor 
perturbation in the core SH3 domain upon addition of the linker. In 
particular, I269, N270 and T289 show the largest chemical shift 
perturbation compared to the cSH3 domain. There are also some peaks 
that had improved line shapes in the presence of the linker, namely A250, 
K253, S272 and N280. Other than these residues, there is little change in 
the HSQC spectrum of the cSH3 domain upon addition of the linker. 
The HSQC spectrum of Crk-ll[lcSH315N] is shown in Figure 2.34. The 
HSQC spectrum of lcSH315N is superimposed. The two HSQC spectra look 
very similar except for line broadening seen in the segmentally labeled 
Crk-ll[lcSH315N]. This arises from the larger size of this construct compared 
to lcSH315N. There are several peaks that have different chemical shifts in 
the two spectra (Figure 2.34). However, the HSQC spectrum of lcSH315N 
has to be assigned before detailed analysis of these differences can be 
made. Efforts at assigning the linker residues are underway. Comparing 
the HSQC spectra of Crk-ll[lcSH315N] and the cSH3 domain shows that 
there are some residues with different chemical shifts between the two 
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spectra (Figure 2.35). Of note, is the peak assigned to the side chain of 
the indole ring of W275. This residue is not perturbed by the addition of 
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Figure 2.33. H S Q C spectrum of lcSH315N (in red) overlaid on the 
spectrum of the cSH3 domain (in black). The two spectra look very 
similar and the linker does not perturb the overall structure of the cSH3 
domain. The residues that have different chemical shifts in the two spectra 
are indicated (assigned in spectrum of the cSH3 domain). The peak for 
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Figure 2.34. H S Q C spectrum of Crk-ll[lcSH315N] (in blue) overlaid on 
the spectrum of lcSH315N (in red). The spectra look very similar 
suggesting that the overall structure of the cSH3 domain does not change. 
There are differences in the line widths of several residues between the 
two spectra. This arises due to the larger size of Crk-ll[lcSH315N]. The 
peaks that have obviously different chemical shifts in the two spectra are 
indicated. Since the H S Q C spectrum of lcSH3 has not been assigned the 
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Figure 2.35. H S Q C spectrum of Crk-M[lcSH315N] (in blue) overlaid on 
the spectrum of the cSH3 (in black). The two spectra look similar except 
for the differences in line widths. The residues that have different chemical 
shifts in the two spectra have been indicated. The residues have been 
assigned in the H S Q C spectrum of the cSH3 domain. 
The changes between the HSQC spectra of the cSH3 domain, 
lcSH315N and Crk-Il[lcSH315N] suggests that there are some differences 
between the domain in isolation and when the domain is in the context of 
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the full length protein. In particular, the chemical shifts of 1269, N270, 
W275 (side chain) and T289 (assigned in the spectrum of the cSH3 
domain) are perturbed when the cSH3 domain is present within full-length 
Crk-ll. The significance of these chemical shift perturbations is not 
completely understood. However, this study represents the first direct 
evidence that the cSH3 domain behaves differently when within the 
context of Crk-ll. A full understanding of this data would require a 
complete assignment of the residues in the lcSH3 domain. This work is 
currently underway in our lab. 
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Chapter 3 - Discussion 
Small modular protein domains have long been used as model 
systems to understand the biophysical properties of proteins. In particular, 
studies on SH3 domains have greatly extended our knowledge of the 
principles underlying protein folding and structure. However, very little is 
known about how their biophysical properties are affected when the 
domain is part of a larger multi-domain protein. This is important because 
modular domains like the SH3 domain are always a part of larger multi-
domain proteins. Thus a detailed understanding of how the functional 
interplay between domains affects their biophysical properties is essential. 
The lack of a generally applicable spectroscopic technique that allows the 
extraction of biophysical information from a specific domain within a multi-
domain protein has hindered this sort of detailed analysis. 
Domain Specific Incorporation of Optical Probes 
Modifying proteins in a site-specific manner with unnatural amino 
acids, particularly ones that can be used as spectroscopic probes, is of 
considerable interest to the protein chemistry community. The introduction 
of Trp analogues into recombinant proteins expressed in E. coli Trp 
auxotrophs has proven a particularly useful strategy for uniformly labeling 
proteins with spectroscopic probes (Mohammadi et al., 2001; Ross et al., 
2000; Shen et al., 1996; Soumillion P, 1995; Twine and Szabo, 2003; 
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Wong and Eftink, 1998a; Wong and Eftink, 1998b). Current approaches 
do not, however, allow one to incorporate Trp analogues into proteins 
containing multiple tryptophans in a site-specific or domain-specific 
manner. This limitation precludes the extraction of domain specific 
biophysical information for large multi-domain proteins (Sato et al., 1999; 
Sato et al., 2000). In this study, this problem was addressed by integrating 
in vivo Trp labeling and protein ligation techniques. This has allowed the 
domain specific incorporation of an optical probe, 7AW, into the SH3 
domain of the adaptor protein, c-Crk-l. 
The SH3 domain of c-Crk-l is small, like most other SH3 domains, and 
has been studied extensively with regards to its biochemical (Knudsen et 
al., 1994), structural (Wu et al., 1995) and biophysical (Camarero et al., 
2001) properties. Its folding properties are similar to other SH3 domains 
such as the src SH3 and a-spectrin SH3 domains (Camarero et al., 2001). 
These attributes make the c-Crk-l SH3 domain an attractive model system 
to explore the effect of context on the functional and thermodynamic 
properties of domains. 
Incorporation of 7AW into the SH3 domain of Crk-I 
There are two Trp residues (Trp169 and Trp170) in this domain that we 
chose to replace with 7AW by bacterial expression in a suitable E.coli Trp 
auxotrophic strain. 7AW incorporation was found to be efficient (;>93%) at 
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both sites as indicated by mass spectrometric analysis of tryptic peptides 
(Figure 2.3). Such high efficiency has been seen before in proteins with 
two or more Trp residues, though the exact reason for this remains 
unknown (Senear et al., 2002). Analysis of the structure of the c-Crk-l SH3 
domain reveals that the 7-position of both Trp residues points out into 
solution. Hence, the incorporation of 7AW was not expected to cause 
structural perturbation in the system (Figure 2.1). Indeed, CD and 
homonuclear 1H NMR spectroscopies indicate that the SH3W and SH37AW 
domains have the same global fold (Figure 2.6, 2.8 and 2.9). This 
conclusion is also supported by thermal (Figure 2.7) and chemical (Figure 
2.11) denaturation experiments, which indicate that the labeled and 
unlabeled proteins have similar thermodynamic stabilities (~3 kcal mol"1) 
(Table 2.2). Lastly, the dissociation constants of the SH3W and SH37AW 
domains, for the peptide ligand used in this study, are essentially the 
same (Figure 2.10 and Table 2.1). Taken together, these results strongly 
suggest that the structural changes caused by the incorporation of 7AW 
into the SH3 domain of c-Crk-l are very minor, if any. 
In contrast, incorporation of 7AW into the cSH3 domain of Crk-ll has 
an energetic cost of ~1 kcal mol"1 (Table 2.5 and Figure 2.29). 
Interestingly, the m-value, which is proportional to the change in solvent 
exposed surface area upon unfolding, decreases when both SH3 domains 
are labeled with 7AW. However, the m-value of the cSH3 domain 
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decreases by ~ 2 7 % while that of the Crk-I SH3 domain decreases by only 
~12% when 7AW is incorporated in these domains. One might expect the 
decrease to be greater in the Crk-I SH3 domain, where two Trp residues 
are replaced by 7AW. One possible reason for this unexpected result is 
that when 7AW in incorporated into the cSH3 domain, it increases the 
solvent accessible surface area in the native state relative to the unfolded 
state. This might not occur in the Crk-I SH3 domain, where both 7-aza 
groups point out into solution. It is also possible that we are populating a 
hidden folding intermediate, which would also explain the larger decrease 
in the m-value. However, the second scenario seems unlikely since we 
have no spectroscopic evidence of any folding intermediates. In the cSH3 
domain the single Trp residue is buried and the 7-position points into the 
hydrophobic core (Figure 2.25). However, the overall fold of the cSH3 
domain is maintained when labeled with 7AW (Figure 2.28). In the case of 
staphylococcal nuclease, this kind of destabilization has also been 
observed when the two Trp residues in that protein are replaced with 7AW 
(Wong and Eftink, 1998a; Wong and Eftink, 1998b). The 7-positions of 
both Trp residues in the nuclease are also buried in the hydrophobic core 
of the protein. This underscores the need for careful thermodynamic and 
structural analysis before labeling a protein with 7AW. In particular, it 
depends on where the 7-position is in the structure of the protein. The 
recent availability of other azatryptophan analogues such as 6AW (Twine 
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and Szabo, 2003) should allow us to choose a label that may cause the 
least perturbation based on the structure of the protein. 
Expressed protein ligation was successfully used to prepare Crk-
l[SH37AW] from its component domains. The ligation reaction was 
extremely efficient (Figure 2.2) allowing multi-milligram amounts of the 
labeled protein to be isolated. Although not relevant for synthesis of Crk-
l[SH37AW], our studies also indicate that the GyrA intein is functional when 
its lone Trp residue is replaced by 7AW (Figure 2.4). Importantly, this 
allows the preparation of a-thioester proteins containing the Trp analogue. 
Thus, our domain specific labeling strategy will be applicable to N-
terminal, C-terminal, and even internal (Cotton et al., 1999) domains of 
large proteins. 
Biophysical Properties of the SH3 domain within Crk-I 
Access to large amounts of Crk-I[SH37AW] has allowed us to investigate 
the effect of context on the thermodynamic and functional properties of the 
SH3 domain by exploiting the spectral characteristics of the 7AW probe. 
These properties do not change dramatically when the domain is present 
in the Crk-I protein (Tables 2.1 and 2.2). Interestingly, the emission 
maxima for SH37AW and Crk-I[SH37AW] differ by around 13 nm (Figure 2.5). 
The blue-shift observed in the Crk-I[SH37AW] spectrum suggests that 7AW 
is present in a slightly different environment (perhaps more hydrophobic) 
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in the context of Crk-I[SH37AW] compared to the isolated domain. 
Conceivably, there might be some interaction between the SH2 and the 
SH3 domains in Crk-I, though this does not have a significant effect on 
either the ligand binding or equilibrium stability of the SH3 domain. Thus, 
these interactions, if present are very weak at best. 
The SH2 domain of Crk-I is extremely stable (Table 2.2). Indeed, the 
free energy of unfolding is significantly higher than has been reported for 
other SH2 domains (AG0H2O ~3 kcal mol"1) (Scalley-Kim et al., 2003; Tzeng 
et al., 2000). As can be seen in Figure 2.11, the SH2 domain remains fully 
folded at intermediate denaturant concentrations at which the SH3 domain 
is completely unfolded, e.g. 2 M GdmCI. This implies that in the context of 
Crk-I[SH37AW], the SH3 domain is unfolding while tethered to the 
presumably folded SH2 domain. Interestingly, this has no effect on the 
thermodynamics of the SH3 domain. Of course, it is possible that the 
stability of the SH2 domain changes when in the context of Crk-I. 
However, this seems unlikely since there are only two domains in the 
protein; any effect caused by one domain on the other should be reflected 
in the equilibrium stability of both domains. Thus we can conclude that the 
thermodynamic properties of the SH3 domain remain unchanged 
regardless of the presence of a fully folded SH2 domain physically linked 
to the SH3 domain. These equilibrium denaturation studies suggest that in 
c-Crk-l, where the domains are linked via flexible non-structured linker 
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regions, the domains fold independently of each other. 
The Signaling Adaptor Protein Crk-ll 
Crk-ll is an alternative spliced form of the Crk-I protein and contains an 
SH2 domain followed by two SH3 domains (nSH3 and cSH3). Crk-ll has 
been implicated in several cellular processes like proliferation, motility, 
phagocytosis and adhesion (Abassi and Vuori, 2002; Akakura et al., 2005; 
Hasegawa et al., 1996; KizakaKondoh et al., 1996; Lamorte et al., 2002a; 
Lamorte et al., 2002b; Reddien and Horvitz, 2000; Sun et al., 2005; Zvara 
et al., 2001) (Figure 1.9). The major difference between Crk-I and Crk-ll is 
that, the latter has a C-terminal SH3 domain (cSH3) that is not present in 
the former. The cSH3 domain is hypothesized to negatively regulate the 
function of Crk-ll via an intramolecular binding event (Feller, 2001; Ozawa 
and Umezawa, 2001). However, understanding the role of the cSH3 
domain in regulating the function first requires structural characterization 
of this domain. 
Solution Structure of the cSH3 domain 
Sequence homology analysis lacks the ability to predict domain 
boundaries with accuracy. Therefore, we used a slightly longer cSH3 
domain construct (L230 to S304) than that predicted by homology to solve 
the NMR structure of the domain. This domain was found to be 
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monomeric at concentrations required for N M R spectroscopy (0.3-0.4 
mM). Steady state 15N-{1H} heteronuclear Overhauser effect (NOE) 
measurements (Figure 2.14) and chemical shift indexing data (Figure 
2.13) showed that there are five p-strands in the cSH3 domain. This data 
also showed that the domain boundaries predicted by sequence homology 
(P237-Q296) were actually quite accurate. This allowed us to exclude 
residues L230 to N235 at the N-terminus and residues P299 to S304 at 
the C-terminus from final structure calculations. In the present work, we 
have found that the cSH3 domain of Crk-ll has the canonical five-stranded 
p-barrel SH3 structure (Figure 2.15). We have also characterized the 
thermodynamic stability and kinetic folding properties of the cSH3 domain 
(Figures 2.22 and 2.23). This allowed us to better understand some of the 
mutational studies performed on Crk-ll. The folding properties of the cSH3 
domain are also comparable to other SH3 domains. 
Ligand Binding Surface of the cSH3 Domain 
In spite of the low sequence conservation, the majority of the SH3 
domains bind to proline-rich sequences (PXXP) via key conserved 
aromatic residues that form a contiguous hydrophobic patch on the 
surface of the protein. Burial of these hydrophobic residues accounts for 
the moderately high affinity (usually low fxM) associated with the PXXP 
binding interaction; ligand binding typically results in the burial of 800-
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1200A2 of surface area, most of which is hydrophobic in nature (Ghose et 
al., 2001; Lee et al., 1996). The specificity of ligand binding arises out of 
ancillary interactions usually involving polar or charged residues flanking 
the core PXXP sequence (Ghose et al., 2001; Wu et al., 1995). By 
contrast, these conserved hydrophobic residues are replaced by non-
aromatic and mostly polar residues in the cSH3 domain (Figure 1.1 and 
Figure 2.18). Indeed, our structure shows that these residues form a 
continuous surface that corresponds to the ligand-binding surface on other 
SH3 domains (Figure 2.18). Consequently, the energy derived from the 
burial of hydrophobic residues upon ligand binding (Clackson and Wells, 
1995) is no longer available in the case of the cSH3 domain. This 
suggests that the cSH3 domain probably does not bind to PXXP 
sequences with high affinity, assuming the interaction is canonical. It is 
also possible that the domain binds to other sequences, as has been 
observed in several SH3 domains including the Pix SH3 domain (Manser 
et al., 1998), the Eps8 SH3 domain (Mongiovi et al., 1999) and the Hbp 
SH3 domain (Kato et al., 2000). It is therefore not surprising that efforts to 
find a PXXP ligand for this domain have not yet been fruitful (Feller, 2001). 
The Putative Nuclear Export Sequence in the cSH3 Domain 
The only known interaction involving the cSH3 domain is with the 
nuclear export factor, Crm1 (Smith et al., 2002). Affinity pull-down assays 
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indicate that the Crk-ll-Crm1 interaction is dependent upon a putative NES 
within the cSH3 domain (L256-V266). Several residues in this sequence 
are part of the hydrophobic core of the domain, namely, L256, L258, V264 
and V266 (Figure 2.17). Recognition of this NES by Crm1 would therefore 
require unfolding of the cSH3 domain to expose the sequence. We 
determined the free energy of unfolding (AG0H2O) of the cSH3 domain to be 
3.66 kcal mol"1 (Figure 2.21). Based on this equilibrium stability, Crm1 
would have to bind to the NES with low nanomolar affinity to compensate 
for the free energy loss associated with the unfolding of the domain. 
Crm1 is thought to bind NES-containing cargoes and RanGTP in a 
cooperative manner with affinities in the nanomolar range (Petosa et al., 
2004). Thus, there could be enough binding energy associated with a 
Crm1-RanGTP-Crk ternary complex to maintain the cSH3 domain in an 
unfolded state (Petosa et al., 2004). This is an intriguing idea and there 
are certainly examples of binding events that maintain proteins in the 
unfolded or partially folded state (Haslbeck et al., 2005; Spiess et al., 
2004). At the same time, it is worth considering the possibility that Crm1 
actually binds to the surface of the folded cSH3 domain. Indeed, the 
principle line of evidence for the involvement of an NES in the CRM1-
cSH3 interaction comes from the inability of Crm1 to bind a cSH3 mutant 
in which residues 263, 264 and 266 are replaced with alanine. As noted 
above, V264 and V266 are part of the hydrophobic core of the protein and 
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thus the native fold of this triple mutant would be expected to be 
dramatically destabilized. Consequently, any binding interaction requiring 
the native SH3 fold would also be weakened. Although Crm1 does not 
contain any PXXP motifs, there are several examples of SH3 domains that 
bind to non-canonical ligands (Kato et al., 2000; Manser et al., 1998; 
Mongiovi et al., 1999) and given the unusual nature of the binding pocket 
in cSH3, such a possibility cannot be discounted in this case. Clearly, 
further biochemical and structural analysis of the Crm1-cSH3 interaction is 
merited. We have also made mutants of the cSH3 domain where L263, 
V264 and V266 have been replaced with alanine. The investigation of the 
thermodynamics and the potential Crm1 interaction of these mutants are 
ongoing. 
Mutational Studies on the cSH3 Domain 
A recent study also alludes to the possibility that the cSH3 domain 
might be involved in the activation of the Abl kinase by Crk-ll (Reichman et 
al., 2005). Abl kinase is known to interact with both the SH2 domain and 
the nSH3 domain of Crk-ll (Anafi et al., 1996; Donaldson et al., 2002; Ren 
et al., 1994). The authors of this study have identified a conserved 
sequence in the RT-loop of the cSH3 domain (P248NAY251) that might play 
a role in the activation of Abl kinase (Reichman et al., 2005). However, 
deletion of this sequence alone does not have an effect on Abl kinase 
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activation (Reichman et al., 2005). Only when combined with other 
mutations in Crk-ll, does the deletion of PNAY sequence show an 
inhibitory effect on Abl kinase (Reichman et al., 2005). In the structure of 
the cSH3 domain, the PNAY sequence points into solution and so is 
available for potential interactions. Several recent studies have shown that 
mutating the single tryptophan residue in the cSH3 domain can lead to the 
disruption of the normal function of Crk-ll (Akakura et al., 2005; Sun et al., 
2005). This tryptophan is an integral part of the hydrophobic core of the 
domain (Figure 2.20). The fluorescence of this tryptophan residue shows a 
robust decrease upon the addition of denaturants, which allowed us to 
follow the folding of this domain. We also replaced the tryptophan residue 
with 7AW, which destabilized the cSH3 domain by ~1 kcal mol'1, about a 
25% decrease in the overall free energy of folding (Figure 2.29 and Table 
2.5). This strongly suggests that the mutation of the tryptophan residue 
unfolds the domain, which leads to the observed deregulation of the 
function of Crk-ll (Akakura et al., 2005; Sun et al., 2005). We have also 
mutated this tryptophan to alanine and the thermodynamic 
characterization of this mutant is ongoing. We are also using this mutant 
to investigate the putative Crm1-cSH3 domain interaction. 
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Regulation of Crk-ll by the cSH3 Domain 
Several lines of evidence indicate that the cSH3 domain acts to 
negatively regulate the function of Crk-ll. Specifically, mutations that 
disrupt the structure of the cSH3 domain interfere with the regulation of 
Crk-ll leading to an abrogation of phagocytosis (Sun et al., 2005) and 
endocytosis (Akakura et al., 2005). The mechanism by which the cSH3 
domain regulates Crk function is unknown. There are no known PXXP-
type binding partners for this domain, despite considerable efforts to 
identify such ligands. As a consequence, several groups have speculated 
on the possibility of intrasteric regulation (Feller, 2001; Ogawa et al., 
1994). In this scheme, the cSH3 domain would participate in an 
intramolecular interaction with another region of the protein, perhaps 
involving the proline-rich sequences within either the SH2 domain or the 
extended linker between the two SH3 domains. 
Several SH3 domains are known to bind ligands in an intramolecular 
fashion (Andreotti et al., 1997; Barila and Superti-Furga, 1998; Groemping 
et al., 2003) and one of the factors governing self-association is the affinity 
of the SH3 domain for the ligand - lower affinities have been shown to 
favor intramolecular binding events (Laederach et al., 2003). Thus, it is 
intriguing to note that the canonical ligand-binding surface of the cSH3 
domain is atypical, being much less hydrophobic and hence likely to lead 
to reduced affinity for PXXP sequences (Figure 2.18). An unexpected 
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feature of the cSH3 domain was the basic nature of its surface (Figure 
2.19). Interestingly, the nSH3 domain of Crk-ll has an acidic surface 
(Figure 2.19). Such a distribution of charges has not been seen in proteins 
with multiple SH3 domains for which structures are available. This poses 
obvious questions about an interaction between the two SH3 domains of 
Crk-ll. 
Domain Specific Labeling to Explore The Mechanism of Regulation 
of Crk-ll by the cSH3 Domain 
Domain specific labeling methods were utilized to explore the 
possibility of an intramolecular interaction mediated by the cSH3 domain. 
The cSH3 domain was labeled with 7AW and 15N within the context of full 
length Crk-ll (Figures 2.26 and 2.27). Labeling of the cSH3 domain with 
7AW replaces the single tryptophan (W275) residue in the domain (Figure 
2.23). Although the difference between 7AW and tryptophan is minor, this 
replacement does destabilize the cSH3 domain by ~1 kcal Mol"1, a 25% 
decrease in the free energy of folding (Table 2.5 and Figure 2.29). The 
destabilization is probably the result of burial of the polar 7-aza group into 
the hydrophobic core of the domain. The overall fold of the cSH37AW 
domain is maintained despite the energetic cost (Figure 2.28). This 
underscores the plasticity of the hydrophobic core of SH3 domains. 
Thermodynamic analysis of Crk-Il[SH37AW] was attempted to analyze 
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the energetics involved in the putative interaction between the cSH3 
domain and the rest of Crk-ll (Figure 2.30). However, the change in 7AW 
fluorescence as a function of increasing amounts of denaturant did not 
result in a curve that could be analyzed. It is possible that under different 
pH, salt or temperature conditions we will get a curve that will allow 
thermodynamic analysis of Crk-II[SH37AW]. Ongoing work in the Muir 
laboratory should address these issues. The fluorescence emission of 
7AW is very sensitive to its local environment. The steady-state 
fluorescence spectrum of Crk-Il[SH37AW] shows a ~22% decrease in 
intensity compared to that of cSH37AW (Figure 2.31). Thus, we can 
conclude that 7AW is present in a different environment in the cSH37AW 
domain compared to Crk-ll[cSH37AW]. 
The HSQC spectra of cSH3, lcSH315N domains and Crk-ll[lcSH315N] are 
similar suggesting that the fold of the cSH3 domain is not changed by 
context (Figures 2.33-2.35). However, there are some key differences 
between the spectra. There are several residues with different chemical 
shifts in the lcSH315N domain compared to Crk-ll[lcSH315N]. Analysis of this 
data requires assignment of the HSQC spectrum of the linker region in 
lcSH315N. There are a few residues that show an obvious chemical shift 
differences in the cSH3 domain compared to lcSH315N and Crk-ll[lcSH315N] 
(Figures 2.33, 2.35 and 3.1). Only one of these residues (T289) is in the 





Figure 3.1. Chemical shift perturbation data mapped on the structure 
of the cSH3 domain. The residues that show obvious chemical shift 
perturbation in the cSH3 domain compared to the domain within Crk-ll are 
indicated in blue. The residues that form the canonical PXXP-type ligand 
binding pocket are shown in orange. T289 is the only residue that is part 
of the canonical ligand binding pocket and also shows chemical shift 
perturbation when the cSH3 domain is within the context of full-length Crk-
ll. 
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Interestingly, the chemical shift of the Trp residue is perturbed only when 
the cSH3 domain is present within full length Crk-ll and not when only the 
linker is added (Figures 2.33 and 2.35). Trp 275 residue is buried right 
under the canonical ligand binding pocket of the cSH3 domain (Figure 
3.1). This suggests that the context of full-length Crk-ll is required to see 
the effects of an interaction between the cSH3 domain and the rest of Crk-
ll. This Trp residue in the cSH33 domain was replaced by 7AW in full-
length Crk-ll. The fluorescence emission spectra of 7AW differ when it is 
present in the cSH3 domain and when the domain is within Crk-ll. Taken 
together, fluorescence and NMR spectroscopies strongly suggest that the 
cSH3 domain interacts with the rest of Crk-ll. This interaction is probably 
key to the role of the cSH3 domain as a negative regulator of Crk-ll 
function. However, we still need to map the interaction surface completely, 
especially the region in Crk-ll that the cSH3 domain binds to. Ongoing 
work in the lab, such as the assignment of the linker region of lcSH3 
domain, will further clarify this issue. Ultimately, the role of the cSH3 
domain in Crk-ll regulation will be best addressed by high-resolution 
structural and thermodynamic analysis on the full-length protein. 
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Conclusions 
We have developed an approach that allows domain-specific 
incorporation of tryptophan analogues within modular, multi-domain 
proteins. In the present example, the methodology was used to probe the 
effect of context on the biophysical properties of the SH3 domain of c-Crk-
1. Comparison of the ligand binding and thermodynamic properties of this 
domain in isolation versus in the context of c-Crk-1 indicates that there are 
few, if any, inter-domain interactions in the protein. 
We have also solved the solution structure and characterized the 
folding properties of the cSH3 domain of Crk-ll. This has led to a better 
understanding of the results of several mutational studies on this domain 
and how it might regulate Crk-ll. Domain specific labeling techniques were 
also applied to generate a 7AW labeled and isotope labeled cSH3 domain 
within full length Crk-ll. Studies on these segmentary labeled molecules 
have offered us several clues as to how the cSH3 domain might regulate 
Crk-ll. These studies have provided the strongest evidence yet that the 
cSH3 domain interacts with the rest of Crk-ll. Ongoing work in the lab will 
further clarify the mechanism of regulation of Crk-ll by the cSH3 domain. 
The techniques developed here should be applicable to many other 
multi-domain proteins, thereby providing the means to dissect the 
biophysical properties of these complex systems. 
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Chapter 4 - Materials and Methods 
General Methods 
All amino acid derivatives and resins were purchased from 
Novabiochem (San Diego, CA) and Peninsula Laboratories (Belmont, CA). 
All other chemicals were purchased from Sigma-Aldrich Chemical Co. (St. 
Louis, MO). Restriction endonucleases were purchased from New 
England Biolabs (Beverly, MA). Analytical RP-HPLC was carried out using 
a Hewlett-Packard 1100 series instrument with 214 nm and 280 nm 
detection. The column used for analytical RP-HPLC runs was a Vydac 
C18 column with a constant flow rate of 1mL/min. Preparative RP-HPLC 
was performed on a Waters DeltaPrep 4000 system using a Vydac C18 
semi-preparative column at a flow rate of 5 mL/min. All runs used a linear 
gradient of buffer A (0.1% (v/v) aqueous TFA) versus buffer B (0.1% TFA 
(v/v), 90% (v/v) acetonitrile). Electrospray mass spectrometry (ESMS) was 
performed on a Sciex API-100 single quadrupole electrospray mass 
spectrometer. MALDI-ToF MS was performed on either a Voyager-DE 
STR instrument (PE Biosystems, Foster City, CA) or a modified Sciex 
prototype QqTOF (Centaur) instrument (Krutchinsky AN, 2000). These 
instruments are equipped with nitrogen lasers delivering pulses of 
ultraviolet light (wavelength 337 nm) at 3 and 20 Hz respectively to the 
sample spot. 
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Cloning and Protein Expression 
Recombinant SH2 (residues 1-124) ethyl a-thioester was prepared as 
previously described (Blaschke et al., 2000). The sequence encoding the 
Crk-I SH3 domain (residues C125 to G207, note that the numbering refers 
to the full-length murine c-Crk sequence) was isolated from Crk-ll cDNA 
by PCR using a 5'-primer (5'- GCCGCGCTCCAGATAGAAGGGCGGTG 
CGGAGTGATTCTCAGGCAGGAGGAGGCAGAG-3') encoding a Xho\ 
restriction site and a 3'-primer (5'- GCGCCGAACTAGTGCATCTCCCG 
TGATGCAACCCTCCTGGTTACCTCCAATCAGAGCCG-3') encoding a 
Spel restriction site. This PCR product was cloned into the plasmid pTXB1 
(New England Biolabs) to make the plasmid pTXB1-Xa-SH3-GyrA-CBD, 
which encodes a Factor Xa site N-terminal to the SH3 domain and Gyrase 
A intein-Chitin Binding Domain (CBD) tag C-terminal to the SH3 domain. 
The plasmid, pTXB1-Xa-SH3-GyrA-CBD is incompatible with 7AW 
labeling primarily because it uses the T7 RNA polymerase for protein 
expression, which is inactive when labeled with 7AW (Ross et al., 1997). 
Therefore, the sequence encoding the SH3-GyrA intein fusion was 
isolated from this plasmid by PCR using the same 5'-primer as when 
constructing pTXB1-Xa-SH3-GyrA-CBD and a 3'-primer (5'-
GCGCCGAAGCTTCTAAGCGTGGCTCACGAACCCGTTCGTGATAAAC 
GC-3') encoding a Hind\\\ restriction site. The PCR product was cloned 
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into the plasmid pTrcHis (Invitrogen), which is compatible with 7 A W 
labeling, to make pTrcHis-Xa-SH3-GyrA, which encodes a Factor Xa site 
between a poly-His tag and the SH3-GyrA intein fusion. We also 
constructed another plasmid, pTrcHis-Xa-SH3, that encodes a stop codon 
between the SH3 domain and GyrA intein, using site-directed 
mutagenesis (Qiagen). All the plasmids were shown to be free of 
mutations in the protein encoding region by DNA sequencing. 
For expression of the unlabeled SH3 domain, SH3W, the Escherichia 
ColiTrp auxtrophic strain CY15077 (kindly provided by the Yale University 
Genetic Stock Center (Yanofsky and Horn, 1995)) transformed with 
pTrcHis-Xa-SH3, was grown to mid-log phase in Luria-Bertani medium 
containing 100 jig/mL ampicillin. Protein expression was induced with 1 
mM IPTG at 37 °C for 6 hours, after which cells were harvested and lysed 
by passage through a French press. The His-tagged fusion protein was 
purified by affinity chromatography using Ni2+ NTA resin (Novagen) and 
dialyzed into Factor Xa cleavage buffer (100 mM sodium phosphate at pH 
7.2, 100 mM NaCl, and 1 mM CaCI2). The fusion protein was then cleaved 
with Factor Xa (Amersham Biosciences) using 100 units of protease/mg of 
protein, over 8-10 hours. The reaction was quenched by the addition of 20 
mM DTT and the cleaved protein further purified by semi-preparative RP-
HPLC using a linear gradient of 25%-45% solvent B over 60 minutes. The 
purified protein was characterized by ESMS as SH3W (Expected mass: 
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9429.5 Da, Observed mass: 9430.4 ± 3.2 Da). The overall yield of SH3W 
domain was 10 mg/L. Protein concentration was determined by UV 
absorption (k =280 nm); SH3W domain, e = 15400 M"1 cm"1. 
For expression of the labeled SH3 domain, SH37AW, an overnight 
culture of the E.co//CY15077 cells transformed with the plasmid pTrcHis-
Xa-SH3 was diluted 1:20 into 6 litres of Luria-Bertani (LB) broth containing 
100 [xg/mL ampicillin. The cells were grown at 37 °C to an Ae00 of 0.9-1.0, 
harvested and then washed with M9 minimal media supplemented with 
0.1 mM CaCI2, 1 mM MgS04> 0.5% glucose, 0.1% thiamine, 100 ug/mL 
ampicillin and 0.6% glycerol. The culture was then resuspended in 6 L of 
M9 minimal media supplemented as above and allowed to grow for 
another 40 minutes to deplete the cellular stores of Trp. Protein 
expression was then induced with the addition of 1 mM IPTG and 80 
ug/mL of D, L-7AW (Sigma) and the cells were harvested after 4 h of 
growth. Subsequent purification and cleavage protocols were the same as 
for SH3W. Purified SH37AW was characterized by ESMS (Expected mass: 
9431.5 Da and Observed mass: 9433.3 ± 1.9 Da). The overall yield of 
SH37AW domain was 1.5-2 mg/L of culture. Protein concentration was 
determined by UV absorption (X =280 nm); SH37AW, e = 22840 M"1 cm"1. 
The cSH3 domain (residues L230-S304) was isolated from Crk-ll 
cDNA by PCR using a 5'-primer (5'-CCGCTCGAGGAGAACCTGTA 
CTTCCAGGGCCTCCCTAACCTCCAGAATGGGCCCATTTATGCCAGG-
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3') encoding a Xho I restriction site and a 3'-primer (5'-
CCCAAGCTTTCAGCTGAAGTCCTCATCGGG-3') encoding a Hind III 
restriction site. The 5'-primer also encoded a poly-His tag and a Tev 
protease site. The PCR product was introduced into pTrcHis plasmid 
(Invitrogen) using Xho\ and Hind\\\ restriction sites. The resulting plasmid, 
pTrcHis-Tev-cSH3, was free of mutations in the protein-encoding region 
as determined by DNA sequencing. The plasmid pTrcHis-Tev-cSH3 
encodes a Tev protease cleavage site between the poly-His tag and the 
cSH3 domain. 
For expression of unlabeled cSH3 domain, the plasmid was 
transformed into E.coli BL21 cells (Invitrogen) and was grown to mid-log 
phase in Luria-Bertani medium containing 100 ^ig/mL ampicillin. Protein 
expression was induced with the addition of 1 mM IPTG at 37 °C for 6 h. 
The cells were then lysed by passage through a French press. Uniformly 
13C and 15N labeled cSH3 domain was produced using the same 
procedure as above, except the cells were grown in M9 minimal media 
supplemented with 2 g/L 13C-glucose and 1 g/L 15NH4CI (Isotec) as the 
sole carbon and nitrogen source, respectively. For labeling the cSH3 
domain with 7AW, the same procedure as mentioned earlier for making 
the Crk-I SH37AW was followed. The His-tagged protein was then purified 
by affinity chromatography using Ni2+- NTA resin (Novagen) and dialyzed 
into Tev cleavage buffer (20mM Tris, pH 8, 0.5mM EDTA and 1mM DTT). 
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Cleavage of the poly-His tag by Tev protease (Invitrogen) results in the 
addition of a glycine residue at the N-terminus of the cSH3 domain. Tev 
cleavage was initiated by the addition of 1 U of protease per 50 mg of 
fusion protein. After 3 days the cleaved product, cSH3, was purified by ion 
exchange chromatography using a HiTrap Q sepharose column 
(Amersham Biosciences) and a linear gradient of 10 mM Tris, pH 7.5 
versus 10 mM Tris, pH 7.5, 1M NaCl at a flow rate of 1 mL/min. The purity 
of the cSH3 domain was assessed to be >95% by HPLC and ESMS 
(Expected mass: 9005.6 Da, Observed mass: 8997.5 ± 3.2 Da). The 
purified cSH3 domain was dialyzed into the NMR buffer (10mM sodium 
phosphate, pH 7.2, 50mM NaCl, 5mM DTT-d10, 0.1% NaN3, 1mM EDTA 
and protease inhibitor cocktail (Roche) to a concentration of 0.3-0.4 mM. 
For fluorescence spectroscopy of cSH37AW, the protein was dialyzed into 
fluorescence buffer (20mM sodium phosphate, pH 7.2, 50mM NaCl). The 
concentrations of the cSH3 domains were determined by UV absorption 
{X= 280). cSH3 domain, e= 8370 M"1 cm"1 and cSH37AW, e= 8470 M"1 cm"1. 
The final yield of the purified cSH3 domain was ~ 5 mg/L and that of 
cSH37AW was ~1 mg/L. 
The lcSH3 domain (residues C208-S304) was isolated from Crk-ll 
cDNA by PCR using a 5'-primer (5'- CCGCTCGAGATAGAAGGG 
CGGTGCCACCCACAGCCACTGGGTGGGCCGG-3') encoding a Xho I 
restriction site and a 3'-primer (5'- CCCAAGCTTTCAGC 
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TGAAGTCCTCATCGGG-3') encoding a Hind III restriction site. The 5'-
primer also encoded a poly-His tag and a Factor Xa protease site. The 
resulting plasmid, pTrcHis-Xa-lcSH3 was shown to be free of mutations in 
the protein encoding region by DNA sequencing. For expression of 
unlabeled lcSH3 domain, the plasmid was transformed into E.coli BL21 
cells (Invitrogen) and was grown to mid-log phase in Luria-Bertani medium 
containing 100 pig/mL ampicillin. Protein expression was induced with the 
addition of 1 mM IPTG at 37 °C for 6 h. The cells were then lysed by 
passage through a French press. Uniformly 15N labeled lcSH3 domain was 
produced using the same procedure as above, except the cells were 
grown in M9 minimal media supplemented with 1 g/L 15NH4CI (Isotec) as 
the sole nitrogen source. For labeling the lcSH3 domain with 7AW, the 
same procedure as mentioned earlier for making the Crk-I SH37AW was 
followed. The His-tagged protein was then purified by affinity 
chromatography using Ni2+- NTA resin (Novagen) and dialyzed into Factor 
Xa cleavage buffer (100 mM sodium phosphate at pH 7.2, 100 mM NaCl, 
and 1 mM CaCI2). The fusion protein was then cleaved with Factor Xa 
(Amersham Biosciences) using 100 units of protease/mg of protein over 8-
10 hours. This exposed the N-terminal cysteine residue required for 
ligation. The reaction was quenched by the addition of 20 mM DTT and 
the cleaved protein further purified by semi-preparative RP-HPLC using a 
linear gradient of 32%-38% solvent B over 60 minutes. The purified 
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protein was characterized by E S M S (for lcSH315N, Expected mass: 
10822.0 Da, Observed mass: 10823.8 ± 1.8 Da and for lcSH37AW, 
Expected mass: 10688.0 Da, Observed mass: 10687 ± 2.8 Da). The final 
yield of purified lcSH315N was ~7 mg/L and that of lcSH37AW was ~2 mg/L. 
Protein concentrations were determined by UV absorption (k =280 nm); 
lcSH315N, e = 10822 M"1 cm"1; lcSH37AW, e = 9630 M"1 cm"1. 
Crk-I (residues M1-G207; SH2 and nSH3 domains) was isolated from 
Crk-ll cDNA by PCR using a 5'-primer (5'- GGGAATTCCATATGG 
CGGGCAACTTCGACTCGG-3') encoding a Nde I restriction site and a 3'-
primer (5'- GGACTAGTGCATCTCCCGTGATGCAACCCTCCTGGTT 
ACCTCCAATCAGAGCC -3') encoding a Spe I restriction site. The 
resulting plasmid, pTXB1-Crk1-GyrA-CBD was shown to be free of 
mutations in the protein encoding region by DNA sequencing. The plasmid 
pTXB1-Crk1-GyrA-CBD encodes for Crk-I followed by the Gyrase A intein 
and a chitin binding domain (CBD). For expression of the Crk-l-GyrA-CBD 
fusion protein, the plasmid was transformed into E.coli BL21 cells 
(Invitrogen) and was grown to mid-log phase in Luria-Bertani medium 
containing 100 ug/mL ampicillin. Protein expression was induced with the 
addition of 0.5 mM IPTG at 37 °C for 6 h. The cells were then lysed by 
passage through a French press. The Crk-l-GyrA-CBD fusion protein was 
then bound to chitin beads (Novagen). The Crk-I protein was cleaved from 
GryA-CBD by incubating the fusion protein bound beads in a buffer 
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containing 100 m M sodium phosphate at pH 7.2, 100 m M NaCl and 2 % 
ethanthiol, overnight at room temperature. After on-bead cleavage of the 
intein to make Crk-I a-thioester, the proteins were eluted with buffer 
containing 6 M guanidinium chloride. Crk-I a-thioester was further purified 
by semi-preparative RP-HPLC using a linear gradient of 35%-55% solvent 
B over 60 minutes. The purified protein was characterized by ESMS 
(Expected mass: 23090.0 Da, Observed mass: 23097.1 ± 4.5 Da). The 
final yield of purified Crk-l-thioester was ~9 mg/L. Crk-I concentration was 
determined by UV absorption (k =280 nm), e = 33920 M"1 cm"1. 
Semi-synthesis of Crk-I[SH37AW], Crk-ll[lcSH37AW] and Crk-ll[lcSH315N] 
Semi-synthesis of Crk-I[SH37AW]. Crk-I[SH37AW] was obtained by chemical 
ligation of SH2-thioester and SH37AW. Ligation reactions were initiated by 
dissolving the purified, lyophilized proteins to a final concentration of 0.2 
mM each, in a buffer containing 100 mM sodium phosphate at pH 7.2, 100 
mM NaCl, 6M guanidinium chloride, 2% MESNA, 2% ethanthiol and 1 mM 
CaCI2. Ligation reactions were allowed to proceed for 4-5 days at 25 °C 
with constant stirring. The product, Crk-I[SH37AW] (residues M1 to G207) 
was purified by semi-preparative RP-HPLC using a linear gradient of 35% 
to 45% solvent B over 60 minutes and characterized by ESMS (Expected 
mass: 23048.5 Da, Observed mass: 23053 ± 5 Da) . In a typical ligation, 6 
mg of purified Crk-I[SH37AW] was obtained from the reaction of 7 mg of 
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SH2-thioester and 3 mg of SH37AW. Crk-I[SH37AW] concentration was 
determined by UV absorption (k =280 nm), e = 33000 M"1 cm"1. 
Semi-synthesis of Crk-ll[lcSH315fJ and Crk-Il[lcSH37AW]. Crk-l-thioester 
was chemically ligated to lcSH315N and lcSH37AW to obtain Crk-ll[lcSH315N] 
and Crk-ll[lcSH37AW] respectively. The ligation reaction to make Crk-
ll[lcSH315N] was initiated by dissolving the purified, lyophilized Crk-l-
thioester to a final concentration of 1 mM and lcSH315N to a final 
concentration of 0.4 mM. The ligation reaction to make Crk-ll[lcSH37AW] 
was initiated by dissolving the purified, lyophilized Crk-l-thioester to a final 
concentration of 0.5 mM and lcSH37AW to a final concentration of 0.4 mM . 
The ligations were carried out in a buffer containing 100 mM sodium 
phosphate at pH 7.2, 100 mM NaCl, 6M guanidinium chloride, 2% MESNA 
and 2% ethanthiol. Ligation reactions were allowed to proceed for 5-7 
days at 25 °C with constant stirring. The products, Crk-ll[lcSH315N] and 
Crk-ll[lcSH37AW] (residues M1 to S304), were purified by semi-preparative 
RP-HPLC using a linear gradient of 39% to 43% solvent B over 60 
minutes and characterized by ESMS (for Crk-ll[lcSH315N], Expected mass: 
33907.6 Da, Observed mass: 33851.0 ± 5.6 Da and for Crk-M[lcSH37AW], 
Expected mass: 33773.6 Da, Observed mass: 33770.0 ± 10.2 Da). In a 
typical ligation, 5 mg of purified Crk-ll[lcSH315N] was obtained from the 
reaction of 20 mg of Crk-l-thioester and 8 mg of lcSH315N. The ligation 
reaction to make Crk-ll[lcSH37AW] was performed once, yielding 1 mg of 
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Crk-ll[lcSH37AW] from the reaction of 12 mg of Crk-l-thioester and 4 mg of 
lcSH37AW. Protein concentrations were determined by UV absorption (X 
=280 nm); Crk-ll[lcSH315N], e = 43560 M"1 cm"1;Crk-ll[lcSH37AW], e = 39310 
M"1 cm"1. The low yields were primarily due to the difficulty in separating 
Crk-I from Crk-ll on RP-HPLC. This was especially acute when making 
Crk-ll[lcSH37AW]. A better way of separating out Crk-I from ligated Crk-ll 
(possibly by ion-exchange chromatography) is needed and will be 
addressed by ongoing work. 
The extinction coefficients (e) for all 7AW containing proteins was 
calculated by using the equation: 
e =(# of Tyr x 1210) + (# of Trp x 5500) + (# of 7AW x 6000) 
All protein concentrations were determined in a buffer containing 6 M 
guanidinium chloride. 
Tryptic digestion and mass spectrometry of SH3W and SH37AW 
Purified SH3W and SH37AW were run on SDS-PAGE using standard 
procedures and the respective bands excised for in-gel trypsin digestion 
(Shevchenko et al., 1996). Extractions of the digest were made as 
described in Shevchenko et al. (Shevchenko et al., 1996)The peptides 
thus derived were then prepared for MALDI-MS using 4-
hydroxycinnaminnic acid (4HCCA) as the matrix. The ultrathin-layer 
method (Tsarbopoulos et al., 1994) was utilized for samples prepared in 
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4HCCA for MALDI-TOF analyses. The MALDI-TOF mass spectrometer 
was operated in the reflectron, delayed extraction mode. The resulting 
data was smoothed and calibrated using Data Explorer (PE Biosystems). 
Fluorescence and Circular Dichroism Spectroscopy 
Steady-state fluorescence spectra of all proteins were recorded 
using a Spex Fluorolog-3 spectroflourimeter. The spectra were recorded 
at 25 °C using an excitation wavelength of 295 nm (for Trp fluorescence), 
310 nm (for 7AW fluorescence) and 5 nm slit widths. In all cases, protein 
concentration was approximately 1 jaM and the protein samples were 
prepared in 20 mM sodium phosphate at pH 7.2, 100 mM NaCl buffer. CD 
spectra were recorded on an Aviv 62DS spectropolarimeter using a 0.1 
cm cuvette. Protein concentrations were 50 \iM in a buffer containing 5 
mM sodium phosphate, 20 mM NaCl buffer at pH 7.2. Spectra were 
recorded at 25 °C in 0.5 nm steps from 260 to 195 nm and averaged over 
4 seconds at each wavelength. The raw CD data (a) was converted to 
mean residue ellipticity ([0]) using the following equation: 
r., gooxv) 
LlJ" [P]nl 
where, a is the CD signal, [P] is the protein concentration in mM, n is the 
number of amino acids and I is the cuvette pathlength in cm. 
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N M R spectroscopy 
NMR samples were prepared by dissolving the purified lyophilized 
protein in a buffer containing 20 mM sodium phosphate (pH 7.2), 20 mM 
DTT-d10, 100 mM NaCl, 10% (v/v) 2H20 and 0.1% (v/v) NaN3 to a final 
concentration of 0.5-1.0 mM. 1D and 2D 1H NMR experiments on the 
nSH3 domain (labeled and unlabeled) were performed on Bruker DPX-
400 and DMX-500 spectrometers at 25 °C. A mixing time of 90 ms was 
used for the TOCSY measurements and 150 ms for NOESY 
measurements. Spectra were assigned based on those reported by Anafi 
et al. (Anafi et al., 1996) for the Crk nSH3 domain in the context of murine 
c-Crk and using assignments kindly provided by David Fushman (personal 
communication). The spectra were analyzed using XWINNMR (Bruker 
Instruments). 
All NMR experiments on the cSH3, lcSH3 domains and Crk-ll[lcSH315N] 
were recorded at 25 °C using Bruker Avance 500, 600, 700 and 800 MHz 
spectrometers (equipped with CryoProbes) and Varian Inova 600 
spectrometers, equipped with triple resonance probes. A mixing time of 
150 ms was used for NOESY measurements on unlabeled cSH3 and 
cSH37AW domains. All NMR data was processed using NMRpipe and 
visualized using NMRDraw (Delaglio et al., 1995). NMRView was used to 
analyze all NMR data (Johnson, 2004). 1H chemical shifts were referenced 
to water at 4.75 ppm (at 25 °C) whereas the Y13C/y1H and y15N/y1H ratios 
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were used for indirect referencing of the 13C and 15N chemical shifts. 1H-
15N-HSQC, 1H-13C-HSQC, 3D-15N-NOESY-HSQC, HNCO, HNCACB, 
CBCA(CO)NH experiments were used to obtain the sequential 
assignment of the backbone (Sattler et al., 1999). Side-chain carbon and 
proton assignments were obtained using C(CO)NH, HC(CO)NH, 
HBHA(CO)NH and HCCH-TOCSY experiments. For assigning the 
aromatic resonances, 1H-13C HSQC, (Hp)Cp(CyCS)H6 and 
(HP)CP(CyC5Ce)He (Yamazaki et al., 1993) and 3D 13C NOESY-HSQC 
data was utilized. 
Dihedral Angle, Distance, Orientation Restraints and Structure 
Calculations 
The backbone dihedral angles {<$> and xji) were calculated by analyzing 
the 13Ca, 13CP, 13C and 15N chemical shifts with the TALOS program that 
predicts the backbone torsion angles from the amino acid sequence and 
chemical shift information (Cornilescu et al., 1999a). The dihedral angles 4> 
were also obtained from the HNHA experiment (Kuboniwa et al., 1994). 
Hydrogen bond restraints were obtained from 2D 3J-HNCO (Cornilescu et 
al., 1999b). Inter-p strand NOEs were also observed for these hydrogen 
bonds. During later stages of structure calculations, these hydrogen bonds 
were added as explicit restraints. These restraints were defined as 1.8-2.3 
A for the H-0 distance and 2.8-3.3 A for the N-0 distance. 
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Distance restraints were derived from 3D 13C-edited N O E S Y (150 ms 
mixing time) and 3D 15N-edited NOESY (150 ms mixing time) experiments. 
Using NMRView, the NOESY cross peak volumes/intensities were 
obtained and converted into distance restraints using the symmetry 
ambiguous distance restraints (ADR) protocol within the ARIA program 
(Habeck et al., 2004; Linge et al., 2003a). This protocol accounts for the 
ambiguity in the NOEs arising from signal overlap and symmetry 
degeneracy. A list of ADR is used to calculate molecular conformations 
and then used to filter the possible assignments. This iterative protocol 
generates a structure ensemble with consistent NOE assignments. The 
ARIA/CNS structure calculations were performed using both manually 
assigned peaks (unambiguous and ambiguous) and unassigned peaks. 
During the various iterations of peak assignments and structure 
calculations, ARIA/CNS either reject the violated peaks or re-assign these 
peaks to a different chemical shift resonance that correlated well with the 
structure. Thus at the end of 8th iteration one would end up with set of 
unambiguous and ambiguous assignments which do not violate. Structure 
calculations were performed using the Cartesian dynamics simulated 
anneling protocol within ARIA/CNS. The following refinement protocol was 
used: a high temperature dynamics 2,000K (10,000 steps), followed by 
Cartesian dynamics cooling stage from 2.000K to 1,000K (6,000 steps) 
which was followed by second cooling stage from 1,000K to 50K (4,000 
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steps). 40 lowest energy structures were further refined in water using the 
protocol described by Linge et. al. (Linge et al., 2003b). The NMR 
structures were displayed and analyzed using MOLMOL (Koradi et al., 
1996), PROCHECK (Laskowski et al., 1996), WHAT IF (Vriend, 1990), 
SwissPDB Viewer (Guex and Peitsch, 1997) and PyMOL (DeLano 
Scientific). The electrostatic potential were calculated SwissPDB Viewer 
and GRASP (Nicholls et al., 1991). The hydrophobic core residue surface 
areas were calculated using MOLMOL (Koradi et al., 1996). 
Ligand binding assays 
A fluorescence based titration assay was used to measure the 
affinity constants of the SH3W domain, SH37AW domain and Crk-I[SH37AW] 
protein for a peptide ligand. All experiments were carried out at 25 °C in a 
stirred 1 cm pathlength cuvette using a Spex Fluorolog-3 
spectroflourimeter. Excitation for the SH3W domain was at 295 nm, 
whereas the 7AW labeled samples were excited at 310 nm. In all cases, 
protein concentration was ~0.1 [iM in 20 mM sodium phosphate (pH 7.2), 
100 mM NaCl. The ligand used in these studies, H-PPPPLPPKRRK[e-
flourescein]G-NH2, was based on a poly-proline sequence from the C3G 
protein (Knudsen et al., 1994) and was prepared by solid-phase peptide 
synthesis using Boc chemistry. Analysis of the changes in the 
fluorescence of the protein solution upon addition of defined 
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concentrations of ligand allowed us to determine the dissociation 
constants. Dissociation constants were calculated by assuming the 
formation of a 1:1 complex (Viguera AR, 1994) and by fitting the corrected 
fluorescence intensities (using non-linear least-squares analysis, 
GraphPad Prism v4.0a) to the equation (Lew J, 1997): 
F_ {DF){P+ Kd+ L |7(P+ Kd+ Lf ~4PL]} 
2P (Eq.1) 
where F and AF are the change and maximum change in protein 
fluorescence respectively, P is the total protein concentration, L is the total 
ligand concentration and Kj is the equilibrium dissociation constant. All 
experiments were repeated three times. Protein and peptide 
concentrations were determined by UV absorption; SH3W, SH37AW and 
Crk-I[SH37AW] as earlier; poly-Pro ligand (X = 495 nm), e = 83000 M'1 cm"1. 
Equilibrium unfolding measurements 
Equilibrium thermal denaturation experiments were performed on 
an Aviv 62DS spectropolarimeter using a 0.1 cm cuvette. The CD signal 
was recorded at each temperature at 220 nm and the signal was averaged 
for 4 seconds. The temperature was varied in 2 °C steps, in both 
directions, between 10 °C to 90 °C with 5 min. incubation at each 
temperature. Protein concentrations were kept at 50 \iM and determined 
as described earlier. Protein samples were dissolved in 5 mM sodium 
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phosphate at pH 7.2, 20 m M NaCl. The C D signal at each temperature 
was fit to the following equation to determine the Tm values (Ramsay and 
Eftink, 1994): 
1 
Yt= l 1 , tx1\Yn + 
'"V- TV 
j h- e rt 
1 
, 1 + e rt 
Yu 
(Eq. 2) 
where, YT is the C D signal at temperature T, T is the temperature, AH is 
the enthalpy of unfolding, Tm is the mid-point of the temperature transition, 
R is the gas constant, YN is the CD signal of the native protein and Yu is 
the CD signal of the unfolded protein. 
Equilibrium chemical denaturation experiments were performed on 
a Spex Fluorolog-3 spectrofluorimeter at 25 °C in a 1 cm pathlength 
cuvette with constant stirring. The fluorescence signals were recorded at 
355 nm for the SH2 domain and 340 nm for the Crk-I SH3W, cSH3 
domains. The Trp residues in these domains were excited at 295 nm. The 
7AW labeled proteins were excited at 310 nm and the fluorescence 
signals were recorded at 361 nm for SH37AW, at 388 nm for Crk-I[SH37AW], 
at 398 nm for cSH37AW and at 400 nm for Crk-ll[lcSH37AW]. Fluorescence 
signals were averaged for 60 sec at each guanidinium or urea 
concentration after a 5 min equilibration period with constant stirring. 
Protein concentrations were 5 \iM (for cSH3 domain), 1 \iM (for SH2, 
SH3W, SH37AW, cSH37AW domains and Crk-ll[cSH37AW]) or 0.5 [xM (for Crk-
l[SH37AW]) in 20 mM sodium phosphate (pH 7.2), 100 mM NaCl. 
113 
Concentrations of guanidinium chloride (denoted [GdmCI]) and urea 
(denoted [Urea]) were determined by measuring the refractive index of the 
solution and using the following equations: 
[Urea]= (117.66)(o, q)+ (29.753)(cx - of + (185.56)(cs, - q)3 
[GdmCI] = (54.147)(q, q)+ (36.68)(q« of + (- 91.6)(q,- q)3 
where, yx is the measured refractive index of the solution and Yi is the 
refractive index of the solution without any denaturant. 
The measured fluorescence signals at each GdmCI or urea concentration 
were fit to the following equation (Pace, 1986): 
{aN + bN[D]+ (au+ bu[D])e" "rt/ 
Fd - - - DGulD] 
1 + e rt (Eq. 3) 
where, 
DGu[D]= dGSz0- m[D] (Eq. 4) 
FD is the measured fluorescence signal. aN, pN, au, and Pu are 
parameters that define the fluorescence signals of the native state (N) and 
the unfolded state (U) as a function of denaturant, [D]. AG°H20 is the Gibbs 
free energy for unfolding in the absence of denaturant. Fraction folded at a 
given denaturant concentration was determined by using FD, aN, pN, a^ 
and Pu. 
Stopped-fiow measurements 
Stopped-flow fluorescence measurements were performed using an 
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Applied Photophysics SX.18MV stopped-flow reaction analyzer equipped 
for asymmetric mixing at a ratio of 10:1. Fluorescence measurements 
were made with an excitation wavelength of 279 nm using a 305 nm cut-
off filter. The refolding and unfolding were initiated by 11-fold dilution of a 
50 \M solution of the cSH3 domain. All solutions contained 10 mM sodium 
phosphate buffer (pH 7.3) and 50 mM sodium chloride. The temperature 
of the syringes and the flow-cell was maintained at 25 °C with a circulating 
water bath. The resulting curves were fitted with a single exponential in 
order to determine rate constants for each reaction. The plots of In kobs 
versus denaturant concentration were fit to the following equation to 
determine the folding and unfolding rate constants in the absence of 
denaturant, k, and ku: 
lnkobS= In (kXe^ffr1) + kXen^r)} (Eq 5) 
where m, and mu are constants that describe the change in In kf and In ku 
as a function of the concentration of denaturant, [D]. 
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